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Abstract 
Haematopoiesis is the developmental process that gives rise to mature blood cells. The 
production of adult blood initiates from the haematopoietic stem cells (HSCs). These cells have 
the ability to give rise to all blood lineages and to self-renew in order to maintain all blood 
lineages throughout the life span of an organism. HSCs emerge de novo from the haemogenic 
endothelium in the ventral wall of the dorsal aorta (VDA), from where they go on to seed adult 
sites of haematopoiesis. Development of HSCs is tightly regulated by several key signalling 
pathways. In particular, Notch signalling is considered an important factor in vascular, arterial 
and HSC development. However, little is known about the role of Notch ligands in 
haematopoiesis process. Morpholino knockdown of the dll4 gene in zebrafish showed that this 
specific Notch ligand is essential for HSC programming. In fact, expression levels of definitive 
HSC markers and runx1, the master regulator of HSC emergence, had their expression levels 
decreased in dll4 morphants. In order to identify novel transcription factors (TFs) and signalling 
molecules involved in this process and that were required in HSC specification, an mRNA-seq 
experiment and a subsequent Go-term analysis for TFs and signalling molecules was previously 
performed in the lab for both dll4 and runx1 morphants.  
In the present study, the expression pattern of the common targets genes differentially 
regulated in both dll4 and runx1 morphants, was assessed by wholemount in situ hybridisation 
(WISH). The results showed that none of the analysed genes were expressed at the region of 
the dorsal aorta (DA), at the time when first HSCs are identified in the VDA. However, follistatin 
a (fsta), which is not expressed in DA but it is an antagonist of a known haematopoietic 
regulator, was also differentially regulated in both morphant and hence it was considered the 
best candidate for further studies.  
Notably, we have shown that Follistatin a is an important regulator of HSC specification 
in the zebrafish, which in turn is regulated, at least in part, by mechanisms dependent on dll4 
and runx1. In addition, functional analysis showed that knockdown of fsta gene leads to an 
increase of HSC derivatives and HSC numbers, thus revealing Fsta as a new potential regulator 
of HSC formation. Strikingly, we also demonstrate that fsta gene regulates venous 
programming, increasing venous sprouting in zebrafish. Taken together, these results add 
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significant new information on the molecular mechanisms surrounding haematopoiesis, 
revealing fsta gene as a downstream target of Dll4/Notch and Runx1 and a critical component 
of the haematopoietic microenvironment that regulates HSC number and venous programming. 
This might contribute to development of novel and safe regulators of haematopoiesis and 
potentially facilitating stem cells based-replacement therapy. 
 
Keywords: dll4, fsta, haematopoiesis, runx1, stem cell. 
  
 
 
iii 
 
Resumo 
A hematopoiese é o processo do desenvolvimento que origina células sanguíneas 
maduras. A produção de todas as células sanguíneas é iniciada a partir de células estaminais 
hematopoéticas (CEHs). Estas células são multipotentes, possuindo a capacidade de auto-
renovação e diferenciação de forma a manter todas as linhagens das células sanguíneas 
durante a vida de um organismo. As CEHs originam-se a partir do endotélio hemogénico na 
parede ventral da aorta. Posteriormente, estas células migram para órgãos específicos, onde 
ocorre a hematopoiese adulta. O desenvolvimento das CEHs é um processo regulado por 
diferentes vias de sinalização. Em particular, a via de sinalização Notch é considerada uma via 
crucial no desenvolvimento vascular, arterial e das CEHs. Porém, o papel dos ligandos desta 
via no processo de hematopoiese não é, ainda, completamente conhecido. Através da 
utilização de um morfolino para o knockdown do gene dll4, foi demonstrado em peixe-zebra, 
que este ligando do receptor Notch é essencial para a programação das CEHs. De facto, tanto 
o número de CEHs maduras, como os níveis de expressão de mARN do factor de transcrição 
Runx1, o principal indutor das CEHs, encontram-se reduzidos nos morfantes de dll4. Com o 
objectivo de identificar novos factores de transcrição e/ou moléculas de sinalização envolvidas 
no processo de especificação hematopoiética, foi realizada uma experiência de mARN-seq em 
ambos os morfantes dll4 e runx1.  
No presente estudo, analisaram-se os alvos significativamente alterados em ambos os 
morfantes (dll4 e runx1) na experiência de mARN-seq, através da técnica wholemount 
hibridização in situ (WISH). A análise demonstrou que nenhum dos genes apresentava um 
padrão de expressão específico para a região da aorta; o local onde as CEHs são 
originalmente formadas e identificadas. No entanto, o gene follistatin a (fsta), expresso na 
região ventral dos somitos e antagonista de um conhecido regulador da hematopoiese, foi 
considerado o melhor candidato para estudos posteriores, uma vez que os seus níveis de 
expressão se encontraram significativamente aumentados em ambos os morfantes. 
Demostrámos que a molécula sinalizadora, Follistatin a, desempenha um papel importante na 
regulação da especificação CEHs no peixe-zebra. De facto, os nossos resultados 
demonstraram que o silenciamento do gene fsta origina um aumento das células derivadas das 
CEHs e, também, do número de CEHs, revelando assim que a Follistatin a é possivelmente um 
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novo e importante regulador da formação de CEHs. Curiosamente, demonstrámos também que 
o gene fsta regula a programação venosa em peixes-zebra, aumentando a angiogénese 
venosa. Em conclusão, os resultados sugerem que o gene fsta, controlado por dll4 e runx1, é 
um modulador crítico do microambiente hematopoiético, regulando o número de CEHs, assim 
como da programação venosa. Estes resultados poderão contribuir, de forma significativa, para 
o desenvolvimento de reguladores do processo hematopoiético e para tornar a utilização das 
células estaminais mais eficaz e segura nas terapias de regeneração. 
  
Palavras-chave: células estaminais, dll4, fsta, hematopoiese, runx1  
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1.1. An overview of haematopoiesis 
Haematopoiesis is the developmental process that gives rise to mature blood cells. 
During the life span of an organism, every second millions of blood cells have to be replaced to 
maintain the blood system. All the blood lineages, including erythroid (erythrocyte), myeloid 
(macrophage, neutrophil, monocyte) and lymphoid (B cell and T cell) are differentiated from 
hematopoietic stem cells (HSCs), which also have the ability to self-renew in order to 
maintaining the HSC numbers throughout life (Loeffler et al., 2011). This is a highly conserved 
process throughout vertebrates (reviewed in (Chen and Zon, 2009). 
In the developing vertebrate embryo, haematopoiesis occurs in discrete waves, termed 
either primitive or definitive. The primitive wave predominantly generate transitory 
haematopoietic cell populations of erythrocytes and some primitive macrophages during early 
embryonic development (Palis and Yoder, 2001); which facilitate tissue oxygenation as the 
embryo undergoes rapid growth (Orkin and Zon, 2008). The definitive wave originates later in 
development, where multipotent HSCs capable of self-renewing and differentiate in all blood 
lineages of the adult organism are produced (reviewed in (Chen and Zon, 2009) (Figure 1.1). 
The HSCs are generated from the endothelium of the ventral wall of the dorsal aorta (VDA) in 
an evolutionarily conserved process (Bertrand et al., 2010; Kissa and Herbomel, 2010). In the 
majority of organisms there is a transient wave of definitive haematopoiesis that produces 
progenitors called erythroid-myeloid progenitors (EMPs) (Bertrand et al., 2007; McGrath et al., 
2011). 
In zebrafish, the embryogenesis occurs during the first 3 days post fertilisation (dpf) and 
can be divided in seven periods: zygote, cleavage, blastula, gastrula, segmentation, 
pharyngula, and hatching periods (Kimmel et al., 1995). During the gastrula period, embryos 
develop three different germ layers - ectoderm, mesoderm and endoderm (Kimmel et al., 1995). 
The haematopoietic cells are differentiated from the mesoderm (Paik and Zon, 2010). The first 
circulating blood cells are just visible after 24 hours post fertilisation (hpf) in zebrafish, however 
during the gastrula period, by approximately 5 hpf, the processes required for HSC generation 
is already happening (Paik and Zon, 2010). 
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Figure 1.1 – Overview of heamatopoiesis. Schematic representation of the blood cells progeny and their specific markers in both primitive and definitive haematopoiesis. 
Figure adapted from (Jagannathan-Bogdan and Zon, 2013). 
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1.2. Haemangioblast and primitive and pre-definitive 
haematopoiesis 
During embryogenesis blood cells arise from the ventral mesoderm via haemangioblast, 
a precursor that generates hematopoietic, endothelial and smooth muscle lineages (Kennedy et 
al., 1997; Motoike et al., 2003; Vogeli et al., 2006). Haemangioblast has the ability to 
differentiate into several tissues including haemogenic endothelium (HE). The HSCs are 
generated from HE through an evolutionarily conserved process called endothelial-
haematopoietic transition (EHT), in which an adherent HE-like cell give rise to a non-adherent 
HSC-like cell (Bertrand et al., 2010; Kissa and Herbomel, 2010). 
In zebrafish, the primitive wave occurs in two distinct embryonic locations: in the 
anterior lateral mesoderm (ALM); and in the posterior lateral mesoderm (PLM), which later 
becomes the intermediate cell mass (ICM) through the migration of the bilateral stripes of cells 
to the midline (Orkin and Zon, 2008). From 10 hpf, bilateral haemangioblast populations in both 
ALM and PLM co-express hematopoietic lineages markers, scl, gata2, and lmo2 transcription 
factors (TFs), and the endothelial lineages markers, kdrl and fli1a TFs (Dooley et al., 2005; 
Gering et al., 1998). The haemangioblast in the ALM specify into either pu.1
+
 myeloid 
progenitors or kdrl
+ 
endothelial cells (Bennett et al., 2001; Lieschke et al., 2002). At 16 hpf the 
pu.1
+
 myeloid progenitors migrate to the midline where primitive myelopoisis occurs, hence 
producing macrophages and granulocytes (Herbomel et al., 1999). At the same time, and 
before the morphogenetic movement of haemangioblasts from the PLM to the ICM, occurs the 
specification of PLM-derived cells (Chen and Zon, 2009). Haemangioblasts in the PLM 
differentiate into gata 1
+
 erythroid progenitors, pu.1
+
 myeloid progenitors and endothelial cells in 
the trunk vasculature (Chen and Zon, 2009). Later between 24 - 26 hpf within the ICM, gata 1
+
 
erythroid progenitors enter the circulation and subsequently mature into primitive erythrocytes 
(Dooley et al., 2005; Gering et al., 1998). Between 24 - 30 hpf at the posterior blood island (PBI) 
(tissue derived from most posterior PLM), a transient wave of definitive haematopoiesis, pre- 
definitive haematopoiesis, generate a population of haematopoietic cells termed EMPs, which 
have the capacity to generate erythroid and myeloid cells (Bertrand et al., 2007) (Figure 1.2). 
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Figure 1.2 – Fate Map of ALM and PLM at 14 hpf in zebrafish. Figure adapted from (Monteiro et al., 
2011). 
 
1.3. Adult-definitive haematopoiesis 
The definitive wave produces HSCs that are capable of generating all the mature blood 
lineages throughout adult life. This wave initiates with the specification of HSCs in a thin 
mesenchyme between the dorsal aorta (DA) and the posterior cardinal vein (PCV) at 24 hfp in 
zebrafish (Murayama et al., 2006); this is a region anatomical and functional homologue of the 
aorta–gonad–mesonephros (AGM) in mammals. These cells express runx1, a TF which is a key 
regulator of definitive haematopoiesis (Kalev-Zylinska et al., 2002; Murayama et al., 2006). 
Then, at 30 hpf, the earliest HSCs emerge from the VDA expressing runx1 through EHT 
process (Kissa and Herbomel, 2010). During this process, these HSCs are release into the 
AGM and sequentially enter into the vein and then migrate to the caudal haematopoietic tissue 
(CHT) in the posterior region of the tail through blood circulation (Bertrand et al., 2010; Dzierzak 
and Speck, 2008; Kissa and Herbomel, 2010). These cells, around 36 hpf, express markers, 
such as runx1,c-myb, CD41 and ikaros in the AGM (reviewed in (Chen and Zon, 2009)). Later, 
at 48 hpf, c-myb
+ 
cells are found in the CHT (Jin and Wen, 2007). By 3 dpf, the expanded HSCs 
(Ikaros
+ 
cells and c-myb
+ 
cells) continue their migration to the thymus, where the lymphopoiesis 
occurs: immature lymphoblast originate T-cells in the thymus. These cells express T cell specific 
markers, such as gata3, ikaros, lck, rag-1 and rag-2 at 4 dpf (Chen and Zon, 2009; Murayama 
et al., 2006). One day later the HSCs (runx1
+
 cells, scl
+
 cells, Ikaros
+
 cells and c-myb
+ 
cells) 
migrate from the AGM and CHT to seed the kidney marrow, which is analogous to the bone 
marrow in mammals, to maintain haematopoiesis throughout life (reviewed in (Jagannathan-
Bogdan and Zon, 2013; Murayama et al., 2006; Zhang et al., 2013). The definitive wave of 
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erythropoiesis begins in the CHT, as indicated by the hbbe1.1 and gata1 expression in this 
region (Zhang and Rodaway, 2007). The definitive erythrocytes gradually replaced the primitive 
erythrocytes and the erythropoiesis switches from the CHT to the kidney (Jin et al., 2009). The 
definitive wave of myelopoiesis is also observed around 3 dpf in the CHT by l-plastin expression 
and then transits from the CHT to the kidney (Jin et al., 2009). As with erythropoiesis and 
myelopoiesis, the site of trombopoiesis begins in the CHT, by approximately 2 dpf, and transits 
to the kidney; by 5 dpf the thrombocytes express CD41 (Lin et al., 2005). 
 
 
Figure 1.3. – Zebrafish haematopoiesis (A) Haemotopoiesis at various sites in zebrafish. The ICM is a 
place of primitive haematopiesis, while definitive haematopoiesis occours in the AGM, CHT and thymus 
and kidney; (B) Timing of haematopiesis in zebrafish; hpf – hours post fertilisation, dpf- days post 
fertilisation. Figure adapted from (Jagannathan-Bogdan and Zon, 2013). 
 
Runx1 is a TF expressed in hematopoietic and neuronal cells during early 
embryogenesis. It has been described as a important player in haematopoiesis, vasculogenesis 
and neuropoiesis (Kalev-Zylinska et al., 2002). In haematopoiesis, Runx1 was defined as key 
regulator of definitive haematopoiesis in all vertebrates (Burns et al., 2002; Kalev-Zylinska et al., 
2002). During development, runx1 gene is expressed in the VDA and modulate both the 
efficiency of HSC emergence from the HE and the survival of these HSCs (Kissa and Herbomel, 
A 
B 
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2010; Lam et al., 2010). Knockdown of runx1 in zebrafish affects definitive haematopoiesis but 
seems to marginally affect primitive erythropoiesis (Burns et al., 2005; Gering and Patient, 
2005; Kalev-Zylinska et al., 2002). When runx1 is lost, the HSC emergence in the DA and its 
activity is lost (Gering and Patient, 2005; North et al., 1999). Curiously, RUNX1 gene has been 
associated with acute leukemia, being the most frequent target for chromosome translocations 
in this disease (Speck and Gilliland, 2002). In fact, 30% of all human leukemias are caused by 
loss-function mutations of RUNX1 (Ito and Miyazono, 2003). 
Although, HSCs are the most well described stem cell systems in the body, their 
ontogeny is not yet completely understood (Medvinsky et al., 2011). In fact, despite the several 
decades of research, a detailed knowledge of the signalling pathways and their interactions with 
TFs that are important for HSC programming is still missing (reviewed in (Marcks-Bluth and 
Pimanda, 2012).  
 
1.4. Programming blood - Signalling pathways that mediate 
haematopoietic stem cell specification 
The production of HSCs during development is a process in which multiple regulatory 
pathways work in concert. Several signalling pathways, such as Wnt, Hedgehog, Vegf, Notch, 
and bone morphogenic protein (BMP), have been identified (Burns et al., 2005; Clements et al., 
2011; Gering and Patient, 2005; Wilkinson et al., 2009). These different pathways are essential 
at different developmental stages of blood programming, from specification and proliferation to 
migration and maintenance (reviewed in (Jagannathan-Bogdan and Zon, 2013; Zhang et al., 
2013)). Despite the decades of research and the knowledge of these molecular pathways 
involved in blood programming, their precise molecular mechanisms and exact temporal-spatial 
activity and integration remain unclear (Loeffler et al., 2011). These signalling pathways 
involved in blood programming, also controlling other developmental and adult cell fate 
decisions. In addition to that, a wide range of ligands and receptors with unclear interactions, as 
well as the potential extracellular and intracellular modifiers involved in these signalling 
pathways make the study of blood programming very complex and difficult (Loeffler et al., 2011; 
Zhang et al., 2013). 
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1.4.1. Notch signalling 
The Notch signalling pathway has been shown to be pivotal in the control of embryonic 
cell fate decisions, including haematopoiesis. This pathway is an important player in stem cell 
regulation and differentiation, and has been described as an important regulator of 
hematopoietic differentiation (Bigas and Espinosa, 2012).  
The Notch signalling network is formed by Notch receptors, ligands, positive and 
negative regulators, and TFs (reviewed in (Pajcini et al., 2011)). The Notch signalling pathway 
through the interaction of their ligands and receptors is able to influences lineage determination 
by two mechanisms of delivery paracrine signals: lateral inhibition - the Notch signalling in one 
cell inhibits Notch signalling of a neighbour cell; and boundary induction - the Notch signalling in 
one layer of cells induces Notch signalling of a neighbour layer of cells (reviewed in (Pajcini et 
al., 2011)). 
 In mammals, there are three transmembrane Notch ligands of the Delta (Dll1, Dll3 and 
Dll4) and two of Jagged (Jag1 and Jag2) families (reviewed in (Pajcini et al., 2011)). In 
zebrafish, there are five ligands of the Delta (dla, dlb, dlc, dld and dll4) and three Jagged ligands 
(jagged 1a, jagged 1b and jagged 2) families (reviewed in (Clements and Traver, 2013). During 
normal Notch signalling, a transmembrane ligand on a particular cell interacts with one of the 
Notch receptors present in other cell, including Notch 1 to Notch 4 in mammals or Notch 1a, 
Notch 1b, Notch 2 and Notch 3 in zebrafish. This in turn, activates Notch receptor by ligand-
induced proteolysis (reviewed in (Clements and Traver, 2013)). In fact, Notch activation occurs 
in two successive proteolytic events which mature the receptor and release an intracellular 
receptor fragment, the Notch intracellular domain (NICD), which then binds DNA-binding 
CBF1/suppressor of hairless/Lag-2 (CSL), and mediates transcriptional activation in 
coordination with the Mastermind (Mam) co-activator (reviewed in (Clements and Traver, 2013; 
Gering and Patient, 2009). The first proteolytic event is mediated by extracellular proteases, 
known as A desintegrin and metalloprotease (ADAM) which cleaves the extracellular domain of 
the Notch receptor (reviewed in (Clements and Traver, 2013; Gering and Patient, 2009). Then, 
the second proteolytic cleavage is mediated by the -secretase complex which releases NICD 
allowing it to translocate into the nucleus, where it associates with the DNA binding protein CSL 
(reviewed in (Caolo et al., 2012; Clements and Traver, 2013; Gering and Patient, 2009). 
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Nuclear translocation of NICD leads to the formation of a transcriptionally active complex 
comprising NICD, CSL and a member of the Mastermind-like (MamL) family, which then recruit 
co-activators and regulates the transcription of downstream genes (Figure 1.4 (A); reviewed in 
(Caolo et al., 2012; Clements and Traver, 2013; Gering and Patient, 2009)  
During embryogenesis, the Notch/Runx1 pathway is a signalling pathway involved in 
regulation of both HSC and arterial and venous specification (Burns et al., 2005; Chen and Zon, 
2009; Jakobsson et al., 2009; Roca and Adams, 2007). In mice, it has been demonstrated that 
Notch1 receptor activates Gata2 (Robert-Moreno et al., 2005), which in turn is one of the critical 
factors for Runx1 activation (Nottingham et al., 2007) and HSC specification (Figure 1.4 B). 
 
 
Figure 1.4 - Overview of Notch Pathway activation. (A) General mechanism of Notch activation by ligand-
induced proteolysis. Figure adapted from (Morrison et al., 2011); (B) Notch ligands expressed by 
neighbouring cells activate Notch receptors to specify HSCs by activating gata2 expression, which in turn 
activates runx1 expression. Figure adapted from (Clements and Traver, 2013). 
 
1.5. Vascular development 
The development of the embryonic blood occurs in association with the developing of 
blood vessels. Indeed, differentiation of blood and endothelial cells occurs from the common 
progenitor, haemangioblast (Vogeli et al., 2006). The blood vessels of the vertebrate circulatory 
system have several crucial functions throughout embryonic and adult life. The circulatory 
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system is formed through the processes of vasculogenesis and angiogenesis, supplying the 
tissues with oxygen and nutrients, removing tissue metabolic wastes, and transporting liquids 
and cells (reviewed in (Lawson and Weinstein, 2002)). The proper formation and maintenance 
of circulatory system is critical during development and after birth (reviewed in (Beets et al., 
2013). The circulatory system can be divided into two types of blood vessels: arteries and veins, 
which are structurally different. In the past, the functional definition of arteries and veins was 
based by the direction of blood flow that they carry out (reviewed in (Lawson and Weinstein, 
2002). Nevertheless, recent findings indicate that the endothelial cells in arteries and veins are 
both functionally and molecularly distinct (Swift and Weinstein, 2009). The arterial-venous 
identity and the establishment of distinct networks of arterial and venous vessels are 
determined in the developing embryo, before circulation begins and are critical for a functional 
circulatory system (reviewed in (Aniket et al., 2012; Lawson and Weinstein, 2002; Swift and 
Weinstein, 2009)). 
 
1.5.1 Vasculogenesis 
Vasculogenesis consist of the de novo formation of blood vessels through the 
coalescence of endothelial cells. This process often involves extensive migration of endothelial 
cells from their point of origin to the site of vessel formation (reviewed in (Lawson and 
Weinstein, 2002). During zebrafish vasculogenesis, angioblasts derived from the posterior 
lateral mesoderm migrates to the midline region to form the DA and PCV in the trunk (Jin et al., 
2005; Lawson and Weinstein, 2002, 2002 ). Endothelial cells expressing Efnb2 gene contribute 
to artery but not to venous specification. Whereas Ephb4, a gene that encodes the putative 
receptor for Efnb2 is expressed in both veins and arteries, but is found in much higher levels in 
veins than arteries (Gerety et al., 1999; Wang et al., 1998). The determination of arterial - 
venous identity has been demonstrated to be related among other with the Vegf-Notch pathway 
(Lawson et al., 2001). 
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1.5.2. Angiogenesis 
Angiogenesis is the formation process of new blood vessels from pre-existing ones. 
After vasculogenesis, angiogenic processes remodel the primary vessel network in order to 
generate a complex vascular network (Isogai et al., 2003). In zebrafish embryonic trunk, 
developmental angiogenesis is a highly coordinated process which takes place in two spatial - 
temporal distinct steps: in the first sprouting angiogenic event, around 20-24 hpf, the primary 
intersegmental vessels (ISVs) originate from the roof of the DA (Blum et al., 2008; Leslie et al., 
2007). Subsequently, these sprouts grow dorsally and reach the top of the neural tube at 
approximately 30 hpf (Leslie et al., 2007), where they bifurcate and extend along the body axis. 
Finally, these longitudinal sprouts connects to form the dorsal longitudinal anastomotic vessel 
(DLAV) (Isogai et al., 2003); the second sprouting angiogenic event is initiated approximately at 
32 hpf from the PCV, during this event intersegmental veins and lymphatic vascular precursors 
are generated, which extend ventrally and interconnect to form the caudal vein plexus (CVP) 
(Isogai et al., 2003; Wiley et al., 2011; Yaniv et al., 2006). These processes are regulated by 
Vegf and their receptors (Wiley et al., 2011). However, it has recently been demonstrated that 
BMP is the main stimulus for sprouting angiogenesis from the PCV, and it is independent of 
Vegf-A. Vegf-A, in turn, is the main stimulus for sprouting from DA (Wiley et al., 2011).  
 
1.6. The zebrafish as a model system 
 Several model organisms have been used to study haematopoiesis process, including 
mice, frog, chick and zebrafish, each of which with its own advantages. Although, during the last 
two decades, the zebrafish (Danio rerio) has been extensively used as model organism for 
studying haematopoiesis, since it combines many attributes of other developmental models 
(Chen and Zon, 2009; Zhang et al., 2013). Indeed, the haematopoiesis associated genes, cell 
types and signalling pathways in zebrafish are highly conserved with those found in higher 
vertebrates, ensuring that lessons from this model might be easily applied to higher vertebrates. 
The zebrafish can be handled in large numbers (~200 eggs per week) and develop 
externally and rapidly (Chen and Zon, 2009; Wolpert et al., 2001). The optical transparency and 
 
 
26 
 
large size of the embryos allow an easy life imaging and make it easier to identify 
developmental abnormalities. Additionally, their external development allows loss-of-function 
experiments using antisense oligonucleotides (through microinjections of RNA and synthetic 
DNA (morpholinos, MO)) or chemical inhibitors dissolved in the water (facilitated by the small 
size of the zebrafish and their ability to absorb chemicals from surrounding water); and gain-of-
function experiments through the overexpression with exogenous RNA or DNA. The zebrafish 
has been proved particularly powerful in the study of haematopoietic and also in the vascular 
development (Chen and Zon, 2009), facilitated by numerous mutants generated from forward 
genetic screens which exhibit haematopoietic and vascular defects and also for the several 
transgenic lines available (Ransom et al., 1996; Stainier et al., 1995; Weinstein et al., 1996). 
Antisense morpholino oligonucleotides are used to specifically knockdown gene 
function (Heasman, 2002). Morpholinos are chemically modified antisense oligonucleotides that 
can specifically inhibit proper gene translation of a target mRNA. The morpholinos are 
analogues to nucleic acids; the ribose ring is replaced with a morpholine ring, and the 
phosphate linkage groups are replaced with non-ionic phosphorodiamidate to provide 
resistance to nucleases (Eisen and Smith, 2008). The morpholinos, can be designed to bind the 
5’ untranslated region (UTR) of a mRNA, or up to 25 nucleotides downstream of the translation 
start site to prevent the translation of the mRNA; or to target splice acceptor or donor sites, 
altering the splicing pattern of the mRNA, which in turn can result in truncated or altered 
proteins degraded, or not, by the cell (Eisen and Smith, 2008; Heasman, 2002). The 
morpholinos persist in the embryos approximately until 5 days after injection and so it is 
important monitor their activity (Chen and Zon, 2009). Thereby they can only be used to 
evaluate gene function during the first few days of development. 
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1.7.  Current and future clinical applications 
The basic HSC research is very important to help us to understand the genetic network 
and molecular aspects controlling the development and functions of stem cells and may 
contribute to treatment of human haematopoietic diseases. These cells are the component of 
the bone marrow which it is used in transplants to treat patients with leukaemia and congenital 
blood disorders (Clements and Traver, 2013). Due to the ability of HSCs to repopulate the entire 
blood system, these cells have successfully been used for cell replacement therapy for several 
years (Loeffler et al., 2011). Despite that, their application has faced several restrictions related 
with immune compatible donors and with the low number of clinically available HCSs. Both 
restrictions could be overcome with the generation of HSCs from patient-specific induced 
pluripotent stem cell (iPSC) or embryonic stem cells (ESCs) (Loeffler et al., 2011). However 
despite decades of research, HSC generation from iPSCs or ESCs has not been accomplished, 
suggesting that key specification requirements are unknown, and so a better understanding of 
how HSCs normally arise during embryonic development is needed (reviewed in (Clements and 
Traver, 2013)). 
 A clear understanding of the molecular mechanisms that leads to the developmental 
specification of HSCs in vivo might provide novel critical insights that will contribute to the 
improving of protocols for efficient generation of HSCs in vitro with regenerative and therapeutic 
purposes (reviewed in (Loeffler et al., 2011; Medvinsky et al., 2011)). 
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1.8 Objectives 
Many important regulators of haematopoiesis and HSC function remain to be described. 
The understanding of the molecular mechanisms required for blood programming in the 
developing embryo will be crucial in designing novel regenerative medicine protocols. The 
generation of HSCs would provide a source of therapeutic cells for blood diseases. Blood 
programming is highly controlled and several signalling pathways, TFs and transcriptional 
complexes have been described as crucial to this process. However, the same TFs and 
signalling molecules are able to interact with different partners in different cell types and display 
different binding patterns, making their study so complex. The HSC research in zebrafish will 
help us to understand the interplay between these TFs/signalling molecules during blood 
programming and therefore will provide new biological insights and likely contribute for novel 
and efficient therapies.  
Previous work in Patient lab has shown that dll4 is required for runx1 expression and 
subsequent for HSC emergence. In addition, a pool of target genes of dll4 and runx1 morphant 
zebrafish, have been established using a mRNA-seq experiment. The work presented here took 
advantage of those observations and more specifically from the list of common target genes of 
dll4 and runx1 previously established, to identify candidate genes with an important role for 
haematopoiesis and hence characterise their potential role in haematopoiesis in the zebrafish.  
Briefly, through a screen by WISH of selected common target genes of dll4 and runx1 
morphants obtained in the mRNA-seq experiment, the general goal of this study was to identify 
novel TFs and/or signalling molecules that possibly regulate the blood programme; Specifically, 
we will investigate the molecular mechanisms and relationships of these novel TFs and/or 
signalling molecules in blood programming by loss-of-function experiments and extend the 
understanding the cellular function of these molecules throughout developmental 
haematopoiesis. 
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2.1. Maintenance and manipulation of zebrafish embryos  
 
2.1.1. Maintenance of fish 
The zebrafish (Danio rerio) used in the present study were maintained in flowing system 
water on a 14 hours light/ 10 hours dark cycle at 28.5 °C, with a conductance between 450-550 
μS, and pH 7.1-7.2. Fish were fed with a mix of flake food, high protein pellets and shrimp (BMS 
Staff, University of Oxford). The experiments involving the use of model organism Danio rerio 
were approved by the University of Oxford research ethics committee. 
 
2.1.2. Zebrafish lines 
The zebrafish lines used in the present study were Tg (lck:Enhanced green fluorescent 
protein (EGFP))
 
(Langenau et al., 2004); Tg (CD41:EGFP) (Lin et al., 2005); Tg 
(kdrl1:GFP/gata1:DsRed) (Jin et al., 2005; Traver et al., 2003). 
 
2.1.3. Staging of zebrafish embryos 
In order to obtain the zebrafish embryos marbles boxes were placed in the tanks for 
approximately 15 hours before the lights came on. After, the eggs were collected and washed in 
system water and placed in Petri dishes with system water or E3 medium supplemented with 
methylene blue (to inhibit fungal growth). The embryos were then grown between 22 °C - 32 °C 
and staged under a dissecting microscope according to (Kimmel et al., 1995). 
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Figure 2.1 – Stages of embryonic development of Zebrafish. Figure adapted from 
(http://www.cores.utah.edu/wp-content/uploads/2013/07/stage2.jpg). 
 
2.1.4.  Microinjection of embryos 
Injections of 0.5 nl of morpholino was performed into the yolk of 1- to 4- cell embryos 
that were positioned against a glass slide. 
 
2.1.5. Dechorionation and fixation of embryos 
The embryos were manually dechorionated with forceps or placed in 1 mg/mL pronase 
solution (diluted in phosphate-buffered saline with tween (PBST)) for the time required for 
removal of the chorions in accordance with the stage of development of the embryo. The 
embryos were fixed in 4% paraformaldehyde (PFA) in PBST for at least 2 hours at room 
temperature or overnight at 4 ºC. Subsequently, embryos were dehydrated into ethanol through 
PBS/ethanol series (25%, 50%, 75% and 100% ethanol) and stored at -20 °C. For embryos 
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younger than 18-somite stage the fixation was performed first and only after that the embryos 
were fixed and stored. 
 
2.2. Solutions, morpholinos, primers 
 
2.2.1. Solutions 
The solutions used in the present study were prepared with MilliQ and autoclaved when 
necessary. All solutions were stored at room temperature, 4 °C (*) or -20 °C (†) (Table 2.1.). 
 
Table 2.1 - List of solutions used in the present study. 
Name Composition 
AP Buffer 100 mM Tris-HCl pH 9.5, 100 mM NaCl, 50 mM MgCl2, 0.1% Tween (freshly made) 
Bleaching 
solution 
10% hydrogen peroxide, 5% formamide, 0.5% SSC (prepared fresh) 
Deyolking buffer 55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO3 
E3 (*) 60 x 1.75% NaCl, 0.08% KCl, 0.3% CaCl2·2H2O, 0.5% MgCl2·6H2O, pH 7.2 
Hybe -/- (*) 50% Formamide, 5x SSC, 9.2 mM Citric Acid, 0.1% Tween 
Hybe +/+ (*) 50% Formamide, 5x SSC, 9.2 mM Citric Acid, 0.1% Tween, 0.05% tRNA, 0.005% 
Heparin LB (Agar(*)) 1%  Bactotryptone, 0.5% Bactoyeast, 1% NaCl, pH 7.0 (1.5% Bactoagar) 
Lysis buffer 2x SDS buffer; 10 mM fresh DTT; 1x proteinase inhibitor (Roche) 
MAB Block (†) 0.1 M maleic Acid, 0.15 M NaCl, pH 7.5, 2% Boehringers Blocking Reagent 
MABT (*) 0.1 M maleic Acid, 0.15 M NaCl, 0.1% Tween, pH 7.5 
MS222 (*) 0.4% Ethyl-3-amino benzoate methanesulfonate salt, pH 7.0 
PBS(T) 0.8% NaCl, 0.02% KCl, 0.15 % Na2HPO4, 0.025% KH2PO4, pH 7.2 (0.1% tween) 
SSC (*) 20 x 3 M NaCl, 0.3 M Sodium Citrate 
SDS 2x 100 mM Tris-HCl pH 6.8, 4%(w/v) SDS, 0,2% (v/v) glycerol 
TAE 50 x 2 M Tris-acetate, 50 mM EDTA 
TBS(T) 0.9% NaCl, 0.02% KCl, 0.3% Tris base, pH 7.4 (0.1% tween) 
TE buffer 10 mM Tris, 0.1 mM EDTA, pH 7.6 
 
2.2.2. Morpholinos 
The morpholinos used in the present study were previously designed to targeting a 
splice junction to alter the splicing pattern and were obtained from Gene Tools, Oregon, USA 
(Table 2.2). The stock solution of morpholino was prepared in MiliQ for a final concentration of 
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50 M and stored at -80 ºC. The working concentration of morpholinos (Table 2.2) was 
prepared in MiliQ and 10% of phenol red and stored at -20 °C. All the morpholinos before used 
were heated to 65 °C during 10 minutes. 
 
Table 2.2. - List of morpholinos used in the present study.  
 
 
2.2.3. Primers 
The primers used in the present study were obtained from Sigma and resuspended to a 
stock concentration 100 M and stored at -20 °C (Table 2.3.). 
 
Table 2.3. - Sequences of primers used in the present study.  
Primer name fwd/rev Sequence (5' - 3') Reference 
ef1α f fwd CACCCTGGGAGTGAAACAG (Patterson et al., 2005) 
ef1α r rev ACTTGCAGGCGATGTGAGC (Patterson et al., 2005) 
T7 fwd TAATACGACTCACTATAGGG Promega 
Sp6 rev ATTTAGGTGACACTATAGAA Promega 
g6pd_Q1f fwd GTCCCGAAAGGCTCCACTC 
reviewed in (McCurley and 
Callard, 2008) 
g6pd_Q1r rev CCTCCGCTTTCCTCTC 
reviewed in (McCurley and 
Callard, 2008) 
rpl13a_Q1f fwd TCTGGAGGACTGTAAGAGGTATGC reviewed in (Tang et al., 2007) 
rpl13a_Q1r rev AGACGCACAATCTTGAGAGCAG reviewed in (Tang et al., 2007) 
fsta Mo_Fw_3 fwd CTGGTAACTGCTGGCTTCAAC This study  
fsta Mo_Rev_3 rev CATTTGCCTTGATACTGGACCT This study  
fsta qPCR_Fw_3 fwd CAACGATGGGATTGTTTACGC This study  
fsta qPCR_Rev_3 rev GGCCTTGATGCATTTTCCTT This study  
sox9b qPCR_Fw_2 fwd GACTACAAATACCAGCCCAGACG This study  
sox9b qPCR_Rev_2 rev AACAGCGCATTGGTGGAGAT This study  
sox21a_1f fwd GCCCATGGATCATGTTAAGC This study  
sox21a_1r rev TGCAGCATATGCCAGGTAAG This study  
Target gene MO MO Target MO Sequence (5’ – 3’) Concetration Reference
fsta fsta MO1 Exon 2 / Intron 2 CAATACTGACGGGATCGTACCTTTA [5-10 ng/nL] Tsukada et al., 2010
dll4 dll4 MO4 Exon 4/ Intron 4 TGATCTCTGATTGCTTACGTTCTTC 6 ng/nL Hogan et al., 2009
re1MO Exon 2 / Intron 2 AGCGCTCTTACCGTATTTGGCGTCC 4 ng/nL Gering & Patient, 2005
re6  MO Intron 5/ Exon 6 GTGTGAATGTGTAAACTCACAGTGT 5 ng/nL
Tessa Peterkin & Philip 
Pinheiro, Patient Lab
runx1
Legend: MO-Morpholino
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neurod4_1f fwd ACGGAAAACCAGGAGATGTG This study  
neurod4_1r rev GGCTCGAAAGCCATGTCTAA This study  
twist3_1f fwd CCCATTGAAGAAGAGCAGGA This study  
twist3_1r rev TAGTGAGTGGCGGACATGG This study  
med18_1f fwd CGTCACGGGTGGAACTATAAA This study  
med18_1r rev GGTGAACGAGAGGTTTGAGC This study  
olig4_1f fwd TCCTCGCCAGATCTCACAGT This study  
olig4_1r rev GAGAGGCTGGCACAAAGAAC This study  
taf5_1f fwd GCTGAAGGAACCAGAGATCG This study  
taf5_1r rev TGTCCAATATCCCACAGCAA This study  
ilf2_1f fwd GGAACCAAGACCTCAGTCCA This study  
ilf2_1r rev CTGGGTCTCCATGCTTTCAT This study  
GTF2A1L_2f fwd CAGTGGCCACCTTCTCTCTG This study  
GTF2A1L_2r rev GTCTGCGTCTCTCTCCTTCG This study  
MAPK12 (1 of 2)_1f fwd CAGGATTTTATCGCCAGGAG This study  
MAPK12 (1 of 2)_1r rev CTGTGTTGTCCATGGAGTGG This study  
CR354435.1_1f fwd CCACCGGCTAAAGCTCCTA This study  
CR354435.1_1r rev TCTTGGGCTTTGCAACTTTC This study  
CABZ01086354.1_1f fwd AAGAAGGGCTCCAAGAAAGC This study  
CABZ01086354.1_1r rev GTACTTGGTGACGGCCTTTG This study  
wu:fe11b02_1f fwd AAGACCGCACCCAAGAAAG This study  
wu:fe11b02_1r rev TGGAGCTGGTGTACTTGGTG This study  
FP236812.2_1f fwd AGGTAAAACCGGAGGCAAAG This study  
FP236812.2_1r rev CAGCCTTCTCGGTCTTCTTG This study  
mcm3_1f fwd GGGAGGCTCAGAGGGATTAC This study  
mcm3_1r rev CAGCACCTTCTCCACTCCTC This study  
zgc:171759.F_1f fwd ATGCCTGAACCCGCTAAAG This study  
zgc:171759.F_1r rev GAGCTGGTGTATTTGGTGACG This study  
rfc3_1f fwd GTGTGGCGATTTTCCTCATT This study  
rfc3_1r rev AAGGCCTCCAGGTGGTAGAT This study  
zgc:110216_1f fwd CCGCCAGCTAAAGCTCCTAA This study  
zgc:110216_1r rev TCTTGGGAGCGGCCTTCTTA This study  
mcm5_1f fwd TGTGGACACTGAAGGAGCAG This study  
mcm5_1r rev TAGCAAGTGACTCCGCAATG This study  
mcm4_1f fwd GTTTCAGCGTTTCCTTCAGC This study  
mcm4_1r rev GTAGATGCTGGGAGCCAGAG This study  
mcm7_1f fwd ATGGCCCCGAAGGATTATAC This study  
mcm7_1r rev AGCTCTTCATCGCTCAGCTC This study  
mcm2_1f fwd TAAACCCGGAGATGAGATCG This study  
mcm2_1r rev CCTGGTCCATCTGGTTGAGT This study  
rag2_1f fwd ACAACGAGCTGTCCTCCAGT This study  
rag2_1r rev CAGATATTGGGGTCCACCTG This study  
polr2b_1f fwd ATGAAATCACCCCTGACCTG This study  
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polr2b_1r rev CGTTCTGCTCCTGAATCACA This study  
paics_1f fwd GTTCGGAAGGATCAGATGGA This study  
paics_1r rev ATGCGAAGAGACGACCAGAT This study  
drap1_1f fwd CGCCGGCTAGAATAAAGAAG This study  
drap1_1r rev TCATCATCGTCCTCCTCCTC This study  
thap11_1f fwd TGCGATTCTACACCTTTCCA This study  
thap11_1r rev TCCTCTTGATGATGGTGTTGG This study  
rfc4_1f fwd CAGGCGTTTCTGAAAGGTTC This study  
rfc4_1r rev GTGCGTGACTCCTTCTCCAT This study  
pcna_1f fwd CACGTCTGGTTCAGGGATCT This study  
pcna_1r rev TTTGACGTGTCCCATGTCTG This study  
mybl2_1f fwd CCCGTGTGCAGTCAGAAAG This study  
mybl2_1r rev TGTTGCCAGCACTGGTTTAG This study  
dnmt1_1f fwd ATTCCTCTGGCTCCTGGTTC This study  
dnmt1_1r rev TCTCCTGCTTCACAGGCTCT This study  
smarce1_1f fwd GCTATGGGAGATTGGCAAGA This study  
smarce1_1r rev CCTCAGGGGTGTTGTCTGAT This study  
tcf7l1a_1f fwd GCCTCTTCTTGACGTTCCTG This study  
tcf7l1a_1r rev ACGAGGTAGGGCTGTCACAC This study  
pold1_1f fwd ACTGAGGGAGGGGAGGACTA This study  
pold1_1r rev TCCTGCATACTCCTGTGCTG This study  
taf9_1f fwd GGAGTACGAACCCAGAGTGG This study  
taf9_1r rev CATCCTCATCTTCATGCTTCC This study  
klf2b_2f fwd CCAGAAGGAGAAGCTCTGGG This study  
klf2b_2r rev GCATGTATGTGTCGCCATGC This study  
FBXL19_1f fwd AGCCAGAGGAGGAGGAAGAG This study  
FBXL19_1r rev TCAGGTGGGAGTCTTTGAGG This study  
terfa_2f fwd ACAACCGGAGATTCACAGGG This study  
terfa_2r rev TCCCAGTGTCCCACACCATA This study  
smarcc1a_2f fwd CTGGCACAGCTCCTGAAGAA This study  
smarcc1a_2r rev GGAGGAGGACCTGGGTACAT This study  
arid2_2f fwd GGTTGATTTCCGAACAACGCA This study  
arid2_2r rev GGAGCACTAGGAGCGTTAGC This study  
sox9b_2f fwd GGACGAGCAGGAGAAGTTCC This study  
sox9b_2r rev GCTGCTCGCTGTACTCTGTA This study  
tcea3_1f fwd AGCCTGGATGGACGAAGAG This study  
tcea3_1r rev CCCCTGCCAAGACATTTTT This study  
rfx1a_1f fwd CAACTCCAGCATACGTGAGG This study  
rfx1a_1r rev ACGGACTGTAGGCTGGTGAC This study  
prox2_1f fwd CAAAGACGAAGAGTGCCACA This study  
prox2_1r rev CCTGACGAGCAAACTTCTCC This study  
dll4_1f fwd TGCAGGACTTTCTTCCGAGT This study  
dll4_1r rev CTTGTGAAAGCATGGGGAAT This study  
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MRAS (1 of 2)_1f fwd GGCAAGAGCGCACTCACTAT This study  
MRAS (1 of 2)_1r rev ATTTGCCTTTCCGCTTTTTC This study  
fsta_1f fwd CCACCCGGGAATGATTTTAT This study  
fsta_1r rev CGCGACTCATCTTTGCATC This study  
dnmt5_1f fwd TGCATTCACTTGCAATCCAG This study  
dnmt5_1r rev AGATCTGCTGGGAAAGATGG This study  
 
2.3. Preparation, manipulation and analysis of DNA 
 
2.3.1. Bacterial culture 
Bacteria were grown at 37 °C for 9–18 hours in liquid culture of Luria-Bertani (LB) 
medium with shaking or solid culture (LB agar) and when necessary cultures were 
supplemented with 100 μg/ml of ampicillin. 
 
2.3.2. Transformation of chemically competent E.coli 
DH5α competent cells (NEB) were incubated with DNA at 4 °C for 30 minutes. Cells 
were heat shocked for 45 seconds at 37 °C and placed immediately at 4 °C for 2 minutes. Then, 
600 μl LB was added and bacteria were grown for 60 minutes at 37 °C before plating on LB 
agar. 
 
2.3.3. Isolation and sequencing of plasmid DNA 
In order to isolate plasmid DNA, was used the Quicklyse mini-kit (Qiagen) following 
manufacturer’s instructions. DNA was eluted in MiliQ and stored at -20 °C. The sequencing of 
the plasmids was done by semi-automated Sanger sequencing (WIMM sequencing service) 
with the appropriate primers and the respective sequences were blasted using National Centre 
for Biotechnology Information (NCBI) website and aligned with multiple alignment server 
ClustalW2. 
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2.3.4. Determination of nucleic acid concentration and purity 
ND-1000 spectrophotometer was used to determine nucleic acid concentration (A260) 
and purity (A230:260:280). Purity was also determined when needed by the profile of the sample on 
an agarose gel. 
 
2.3.5. Agarose gel electrophoresis 
Nucleic acids were analysed in a 1% or 1.5% agarose/0.5 X TAE gel supplemented with 
0.01% GelRed (Cambridge Bioscience). The gel was run at 100 V in 0.5 X TAE and the nucleic 
acid was visualised/photographed/analysed using ChemiDoc MP System and Image Lab 
software (BioRad). 100 bp and/or 1KB DNA ladders (NEB) were used. 
 
2.3.6. Restriction enzyme digestion and DNA ligation 
DNA was digested for 2-16 hours with the specific restriction enzyme and buffer (NEB) 
following manufacturer’s instructions. To confirm the digestion, part of the sample was analysed 
by electhrophoresis. The ligations were performed in general, using a 1:1 molar ratio of the DNA 
fragment to the vector (pGEM-T Easy) and using T4 DNA ligase and ligase buffer (Promega) 
following manufacturer’s instructions. The ligation reactions were incubated overnight at 4 ºC 
and then used to transform bacteria. 
 
2.3.7.  DNA purification and gel extraction 
DNA was clean by QIAGEN QIAquick PCR Purification Kit (Qiagen) following 
manufacturer’s instructions. For the gel extraction of DNA, after electrophoresis the gel was 
placed on a UV box and the specific band which we wanted purify was cut and purified using 
QIAquick Gel Extraction Kit following manufacturer’s instructions. 
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2.3.8.  Polymerase chain reaction 
PCR reactions were prepared using 10 pmol of forward and reverse primer and 
JumpStart taq (Sigma) following manufacturer’s instructions. In general the PCR conditions 
used were: 95 ºC for 3 minutes and 30 cycles of: 95 ºC for 15 seconds; 56 ºC for 45 seconds 
and 72 ºC for 1 minute and 30 seconds; and a final step of extension of 72 ºC for 7 minutes. 
The reactions were analysed on agarose gels. 
To perform colony PCR initially individual colonies were picked and resuspended in 20 
μl of MiliQ. Then, the colony PCR reactions were prepared using 5 μl of the colony suspension, 
10 pmol of forward and reverse primer and JumpStart taq (Sigma) following manufacturer’s 
instructions. The PCR reactions were placed in the thermocycler (DNA engine) and the 
conditions used were: 95 ºC for 5 minutes and 30 cycles of: 95 ºC for 30 seconds; 55 ºC for 45 
seconds and 72 ºC for 1 minute and 10 seconds; and a final step of extension of 72 ºC for 7 
minutes. And by last the reactions were analysed on agarose gels for determine the positive 
clones and then, the remaining 15 μl of colony suspension from the positive colonies was used 
to inoculate liquid culture. 
 
2.4.  RNA preparation, manipulation and analysis 
 
2.4.1. Isolation of total RNA 
For total RNA isolation, the zebrafish embryos were homogenised in 500 μl TRIzol 
(Sigma) by a homogenizer. After, further 500 μl TRIzol the cell debris was removed by 
centrifugation. For the isolation of the nucleic acids was added 200 μl chloroform, the sample 
was mixed and centrifuged and the aqueous phase which contained the nucleic acids was 
removed for a new tube. Then, RNA was precipitated with 500 μl isopropanol; the supernatant 
was removed and the RNA pellet washed with ethanol 70% and centrifuged; Then RNA pellet 
was air dry and resuspended in MiliQ; For quantitative real-time PCR (qRT-PCR), the RNA 
isolation was performed using RNeasy Mini Kit (Qiagen) following manufacturer’s instructions. 
Isolated RNA was stored at -80 °C. 
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2.4.2. Reverse transcription of RNA 
In order to produce cDNA, the reverse transcription of RNA was performed using: 1 μg 
of RNA, 1 mM dNTPs (Invitrogen) and 25 ng/µL random primers (Invitrogen) for a total volume 
of 20 μl. RNA was made up to 10.5 μl and heated to 65 °C for 5 minutes, then placed at 4 °C for 
3 minutes. After addition of 1X FS Buffer (Invitrogen), 0.1 M DTT (Invitrogen) and 0.5 μl Rnasin 
(Invitrogen) the tube was incubated at room temperature for 2 minutes and then 0.5 μl of 
reverse transcriptase RT - SuperScript III enzyme (Invitrogen) was added. Then the reaction 
was placed thermocycler (DNA engine) and the conditions used were: 21 °C for 10 minutes, 50 
°C for 50 minutes and 85 °C for 5 minutes. For RT-PCR, was added to the cDNA 30 μl of MiliQ 
and 1 μl used per reaction. For qRT-PCR, was added to the cDNA 180 μl of MiliQ and 3 μl used 
per reaction. The cDNA was stored at -20 °C. 
 
2.4.3. Quantitative real-time RT-PCR 
qRT-PCR assays were performed using the Applied Biosystem 7500 real-time cycler 
and FAST SYBR green following manufacturer’s instructions. We used FAST SYBR green 
master mix (Applied Biosystems) in a final volume of 20 μL containing 3 μL of cDNA diluted 1:10 
in MiliQ, 1 μL of each primer and 18 μL of FAST SYBR green (Applied Biosystems). Each 
reaction was carried out in triplicate and the specificity of the primers was tested by the analysis 
of the melting curve. The data analysis was performed using the ΔΔCt method (Dussault and 
Pouliot, 2006). The Ct values were normalized to the glucose-6-phosphate dehydrogenase 
(g6pd) endogenous housekeeping gene. The result presented in the present study corresponds 
to one biological sample (with three technical replicates) but was reproduced in another 
biological sample. Error bars were representative of the standard deviation about the mean, and 
significance assessed by a two-tailed Student’s t-test (P < 0.05 was considered to be 
significant). 
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2.5. Isolation and analysis of Protein 
 
2.5.1. Deyolking of zebrafish embryos, polyacrylamide gel electrophoresis and 
western blotting 
To perform western blot analysis approximated 40 zebrafish embryos per condition 
were deyolked in 500 l of deyolking buffer (Table 2.1) followed by homogenization by pipetting 
through a 200 μl tip and shaken at 1100 rpm for 5 minutes at 4 ºC (Thermomixer, Eppendorf). 
Next, the supernatant was removed after centrifugation at 300 g for 30 seconds and the pellet 
was stored at -80 °C until necessary or was immediately lysed at 4 ºC with the lysis buffer (1 l 
/embryo) (Table 2.1). In order to destroy genomic DNA, the samples were sonicated. Then, the 
samples were heated to 90 °C for 5 minutes and placed immediately at 4 °C. Supernatant 
proteins and Rainbow marker (Amersham) were run on 10% Bis-Tris polyacrylamide precast gel 
placed in MES SDS running buffer (Invitrogen) for 30 minutes at 100 V and afterwards at 200 V. 
Then the proteins were transferred to a Trans-Blot
 
Turbo Mini nitrocellulose membrane (BioRad) 
by Trans-Blot Turbo transfer starter system (BioRad). The membrane was washed in tris- 
buffered saline with tween (TBST) and blocked for 1 hour in 5% non-fat milk (Sigma) in TBST. 
The blots were incubated in 1:500 rabbit anti-Follistatin a (Sigma SAB2701665) in blocking 
solution overnight at 4 °C. Then, the blots were washed 3 x 10 minutes in TBST and incubated 
in 1:10 000 anti-rabbit IgG – peroxidise antibody produced in goat (Sigma A0545) for 1 hour at 
room temperature and washed again 3 x 10 minutes. All antibody incubations and washes were 
performed with gentle rotation and rocking. The blots were laid on a flat surface and covered 
with enhanced chemiluminescence developing reagent (Santa Cruz Biotechnology, Inc) at room 
temperature for 5 minutes and placed into a plastic cover and exposed to photographic film 
(Kodak) in the dark for the appropriate time. The film was developed in WIMM developing facility 
following manufacturer’s instructions and the image digitised at 300 dpi. After, the membrane 
was stripped with Restore Stripping buffer (Thermo Scientific) for 20 minutes at room 
temperature and re-blocking as mention above and incubated with monoclonal anti-β-Actin-
peroxidase conjugated (Sigma A3854) at 1:35 000 as a loading control. Next was performed the 
washing and developing steps as mentioned above. 
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2.6. Construction and in vitro synthesis of antisense probes 
 
2.6.1. Novel antisense probe constructs 
The construction of novel antisense probes in the present study  was performed through 
the amplification by PCR of approximately 500 – 1000 bp of the genes of interest using as 
template Wild type (Wt) cDNA of 26 hpf zebrafish embryos and specific primers designed based 
on ENSEMBL sequences (www.ensemble.org) (Table 2.3). The PCR product was analysed in 
agarose gel and cloned into the pGEM-T Easy vector system (Promega) following 
manufacturer’s instructions. Then, was performed colony PCR for some of the resultant 
colonies, and the positive clones were grown and plasmid DNA was extracted and sequenced 
with T7 and Sp6 primers to confirm which restriction enzyme and RNA polymerase should be 
used to linearize the plasmid and synthesised the probe respectively. 
 
2.6.2. in vitro synthesis of antisense probes 
For the synthesis of the antisense probes was prepared a reaction of 20 μl containing: 1 
μg of linearised DNA plasmid; 1 μl of appropriate RNA polymerase (Sp6, T3 or T7) (Table 2.4), 
0.5 μl RNaseOUT (Invitrogen), 2 μl DIG-dUTP NTP mix (Roche) and the appropriated buffer. 
The reaction was incubated at 37ºC during at least 2 - 6 hours depending of the RNA 
polymerase. Then, was added 1 μl of DnaseI (NEB) and the reaction was incubated for 15 
minutes at 37 ºC. To stop this reaction 80 μl of MiliQ and ethylenediaminetetraacetic acid 
(EDTA) at a final concentration of 10 mM was added. After, the probe was precipitated with 1/3 
volume 10 M ammonium acetate (NH4Oac) and 2.5 volumes ethanol. The probe was then 
centrifuged at 4 ºC and the pellet was washed with 70% ethanol and centrifuged again; the 
pellet was air dried and resuspended with MiliQ. The purity of the probe was analysed on an 
agarose gel and the probe was stored at -20 ºC.  
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Table 2.4. - List of antisense riboprobes used in the present study.  
Gene name Restriction Enzyme RNA Polimerase Primer Forward (5'-3') Primer Reverse (5'-3') Reference 
arid2 NdeI T7 GGTTGATTTCCGAACAACGCA GGAGCACTAGGAGCGTTAGC This study  
CABZ01086354.
1 
Nsil T7 AAGACCGCACCCAAGAAAG GTACTTGGTGACGGCCTTTG This study  
c-myb EcoRI T7   (Thompson et al., 1998) 
CR354435.1 SacI T7 CCACCGGCTAAAGCTCCTA TCTTGGGCTTTGCAACTTTC This study  
dll4 SpeI T7 TGCAGGACTTTCTTCCGAGT CTTGTGAAAGCATGGGGAAT This study  
dll4 SpeI T7   Martin Gering, unpublished 
dnmt1 NcoI Sp6 ATTCCTCTGGCTCCTGGTTC TCTCCTGCTTCACAGGCTCT This study  
dnmt5 SphI Sp6 TGCATTCACTTGCAATCCAG AGATCTGCTGGGAAAGATGG This study  
drap1 NcoI Sp6 CGCCGGCTAGAATAAAGAAG TCATCATCGTCCTCCTCCTC This study  
FBXL19 ApaI Sp6 AGCCAGAGGAGGAGGAAGAG TCAGGTGGGAGTCTTTGAGG This study  
flk1 EcoRI T7   (Fouquet et al., 1997) 
foxn1 SalI T7   (Wilkinson et al., 2009) 
FP236812.2 SphI Sp6 GGGAGGCTCAGAGGGATTAC CAGCCTTCTCGGTCTTCTTG This study  
fsta NcoI Sp6 CCACCCGGGAATGATTTTAT CGCGACTCATCTTTGCATC This study  
GTF2A1L NcoI Sp6 CAGTGGCCACCTTCTCTCTG GTCTGCGTCTCTCTCCTTCG This study  
ikaros SalI T3   (Willett et al., 2001) 
ilf2 SphI Sp6 GGAACCAAGACCTCAGTCCA ATGAAAGCATGGAGACCCAG This study  
klf2b NcoI Sp6 CCAGAAGGAGAAGCTCTGGG GCATGTATGTGTCGCCATGC This study  
MAPK12 (1 of 2) SphI Sp6 CAGGATTTTATCGCCAGGAG CTGTGTTGTCCATGGAGTGG This study  
mcm2 NcoI Sp6 TAAACCCGGAGATGAGATCG CCTGGTCCATCTGGTTGAGT This study  
mcm3 AatII Sp6 ATGCCTGAACCCGCTAAAG CAGCACCTTCTCCACTCCTC This study  
mcm4 SpeI T7 GTTTCAGCGTTTCCTTCAGC GTAGATGCTGGGAGCCAGAG This study  
mcm5 ApaI Sp6 TGTGGACACTGAAGGAGCAG TAGCAAGTGACTCCGCAATG This study  
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mcm7 SpeI T7 ATGGCCCCGAAGGATTATAC AGCTCTTCATCGCTCAGCTC This study  
med18 Nsil T7 CGTCACGGGTGGAACTATAAA GGTGAACGAGAGGTTTGAGC This study  
mpx EcoRI T7   (Bennett et al., 2001) 
MRAS (1 of 2) NdeI T7 GGCAAGAGCGCACTCACTAT ATTTGCCTTTCCGCTTTTTC This study  
mybl2 SpeI T7 CCCGTGTGCAGTCAGAAAG TGTTGCCAGCACTGGTTTAG This study  
neurod4 SpeI T7 ACGGAAAACCAGGAGATGTG GGCTCGAAAGCCATGTCTAA This study  
olig4 NdeI T7 TCCTCGCCAGATCTCACAGT GAGAGGCTGGCACAAAGAAC This study  
paics NcoI Sp6 GTTCGGAAGGATCAGATGGA ATGCGAAGAGACGACCAGAT This study  
pcna SphI Sp6 CACGTCTGGTTCAGGGATCT TTTGACGTGTCCCATGTCTG This study  
pold1 NcoI Sp6 ACTGAGGGAGGGGAGGACTA TCCTGCATACTCCTGTGCTG This study  
polr2b NcoI Sp6 ATGAAATCACCCCTGACCTG CGTTCTGCTCCTGAATCACA This study  
prox2 SpeI T7 CAAAGACGAAGAGTGCCACA CCTGACGAGCAAACTTCTCC This study  
rag1 HindIII T7   (Willett et al., 1997) 
rag2 NdeI T3   (Willett et al., 1997) 
rfc3 SpeI T7 GTGTGGCGATTTTCCTCATT AAGGCCTCCAGGTGGTAGAT This study  
rfc4 SphI Sp6 CAGGCGTTTCTGAAAGGTTC GTGCGTGACTCCTTCTCCAT This study  
rfx1a NcoI Sp6 CAACTCCAGCATACGTGAGG ACGGACTGTAGGCTGGTGAC This study  
runx1 HindIII T7   (Kalev-Zylinska et al., 2002) 
smarcc1a ApaI Sp6 CTGGCACAGCTCCTGAAGAA GGAGGAGGACCTGGGTACAT This study  
smarce1 NcoI Sp6 GCTATGGGAGATTGGCAAGA CCTCAGGGGTGTTGTCTGAT This study  
sox21a SpeI T7 GCCCATGGATCATGTTAAGC TGCAGCATATGCCAGGTAAG This study  
sox9b SphI Sp6 GGACGAGCAGGAGAAGTTCC GCTGCTCGCTGTACTCTGTA This study  
taf5 SphI Sp6 GCTGAAGGAACCAGAGATCG TGTCCAATATCCCACAGCAA This study  
taf9 NcoI Sp6 GGAGTACGAACCCAGAGTGG CATCCTCATCTTCATGCTTCC This study  
tcea3 SpeI T7 AGCCTGGATGGACGAAGAG CCCCTGCCAAGACATTTTT This study  
tcf7l1a SpeI T7 GCCTCTTCTTGACGTTCCTG ACGAGGTAGGGCTGTCACAC This study  
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terfa NcoI Sp6 ACAACCGGAGATTCACAGGG TCCCAGTGTCCCACACCATA This study  
thap11 SphI Sp6 TGCGATTCTACACCTTTCCA TCCTCTTGATGATGGTGTTGG This study  
twist3 NdeI T7 CCCATTGAAGAAGAGCAGGA TAGTGAGTGGCGGACATGG This study  
wu:fe11b02 SpeI T7 AGGTAAAACCGGAGGCAAAG TGGAGCTGGTGTACTTGGTG This study  
zgc:110216 NdeI T7 CCGCCAGCTAAAGCTCCTAA TCTTGGGAGCGGCCTTCTTA This study  
zgc:171759.f SphI Sp6 CGCCCAAGAAGGGATCTAA GAGCTGGTGTATTTGGTGACG This study  
hbbe1.1 XhoI T3   
(Quinkertz and Campos-Ortega, 
1999) 
 
The probes were produced using linearised plasmids digested with the indicated restriction enzyme and with the indicated RNA polymerase. 
 
 
 
45 
2.7. Wholemount in situ hybridisation 
Wholemount in situ hybridisation (WISH) was performed in fixed embryos in 100% 
ethanol. Initially the embryos were rehydrated to PBST using a graded ethanol/PBST series 
(75%, 50% and 25% ethanol) and washed 4 x PBST; each wash was perform for 5 minutes at 
room temperature with gentle rocking. Then, the embryos were subjected or not to treatment 
with proteinase K, with a specific concentration in accord to their development stage. The 
treatment of proteinase K was stopped by washing the embryos 2 x 5 minutes with 2 mg/ml 
glycine in PBST at room temperature with gentle rocking. The embryos treated with proteinase 
K were washed 2 x 5 minutes with PBST at room temperature with gentle rocking and finally 
fixed with 4% PFA for 20 min. All the embryos (subjected or not to treatment proteinase K) were 
extensively washed 5 x 5 minutes in PBST at room temperature with gentle rocking. After this, 
the embryos were transferred to 50% hybe+/+ in PBST for 5 min, then 100% hybe+/+ for at 
least 1 hour at 65 °C. Finally, the embryos were incubated overnight at 65 ºC with probe diluted 
at 1:200 in hybe+/+. 
The second and third day of the WISH protocol was performed using Biolane HT-1 in 
situ machine (Intavis) with gentle rocking. After removal of the probes the embryos were 
transferred to a plate of 24 or 48 wells and placed on in situ machine (Intavis). Embryos were 
washed at 65 °C through hybe -/- / 2 x saline sodium citrate (SSC) series, (100%, 75%, 25% 
hybe-/- in 2 x SSC, and a 100% 2 x SSC), each wash was done for 10 minutes; then the 
embryos were washed 4 x 15 minutes in 0.2 x SSC. At room temperature, embryos were 
washed through 0.2 x SSC / MABT series (75%, 50%, 25% 0.2 x SSC in MABT and 100% 
MABT) and each wash was done for 5 minutes. Then was done the blocking, incubating the 
embryos with MAB block for 1 hour at room temperature. The embryos were incubated with 
anti-DIG antibody (Roche) at 1:5000 in MAB block at 4 °C for 10 hours. After, the embryos were 
washed 8 x 15 minutes in MABT and 3 x 5 minutes in AP buffer at room temperature. After this 
the embryos were transferred for a disposable plate of 24 or 48 wells and was added the 
developing solution (BM Purple (Roche) mixed 1:1 with AP buffer) to the embryos. The plate 
was placed on the rocker at room temperature or 4 ºC and the staining was controlled by 
analysis under the light microscope; the staining was stopped by fixation in 4% PFA for at least 
20 minutes at room temperature followed by 3 x 5 minutes washes in PBST at room 
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temperature with gentle rocking. For embryos older than 26 hpf a additional step of bleaching 
was performed in order to remove the pigments and so improve the analysis of the WISH signal 
The embryos were bleached with bleaching solution (Table 2.1) on a light box during the 
necessary time for their development stage; then were washed 3 x 5 minutes in PBST at room 
temperature with gentle rocking. After the PBST washes all the embryos were stored in 80% 
glycerol and placed at 4 ºC until their analysis under the microscope. 
 
2.8. Embedding and Sections of Zebrafish Embryos 
For histological analysis, embryos after WISH were fixed overnight in 4% PFA at 4 ºC. 
Fixed embryos were washed 2 x 30 minutes in PBST, and dehydrated in 50%, 70%,85%, and 
95% of ethanol washes for 30 minutes each, and 3x 30 minutes in 100% ethanol, and then were 
stored overnight at 4ºC. Dehydrated embryos were washed 2 x 30 minutes in 100% xylene at 
room temperature and next in 1:1 xylene/wax for 45 minutes at 70 ºC. After the embryos were 
washed 4x 30 minutes in 100% wax at 70 ºC and incubated overnight in 100% wax at 70 ºC. 
Finally the embryos were mounted in the correct orientation in a plastic embedding container 
with 100% wax. Wax sections were prepared using a Leica rotary microtome and the resulting 
10–15 µm sections were mounted onto glass slides. At last, the wax was removed from the 
sections through 3 x 5 minutes washes with xylene and the contrast staining was performed 
using neutral red (Vector Laboratories). The glass slides of the sections were place into the 
solution of neutral red for 3 minutes, rinse with water, and finally dehydrated with ethanol and 
clear with xylene.  
 
2.9. Imaging zebrafish embryos 
 
2.9.1. Still digital photography 
In order to acquire pictures of the zebrafish embryos, the embryos were placed under a 
light dissecting microscope which had attached a Q-Imaging Micropublisher 5.0RTV camera 
with Q-Capture Pro 7 software. The embryos were mounted in 100% glycerol or for live 
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embryos were imaged in 1:30 E3 medium/MS222 or mounted in 3% methylcellulose. For the 
picture manipulation was used Adobe Photoshop CS5.  
 
2.9.2. Wide field fluorescence imaging  
For the analysis of transgenic lines the embryos were imaged on a SteREO Lumar.V12 
microscope (Zeiss). The acquisition and analysis of the pictures were performed with the Zeiss 
AxioVision software. For the picture manipulation was used Adobe Photoshop CS5. 
 
2.10. Bioinformatics tools: Blast and Sequence alignment 
Sequences were blasted using NCBI website (www.blast.ncbi.nlm.nih.gov/) and aligned 
with multiple alignment server ClustalW2 (www.ebi.ac.uk/Tools/msa/clustalw2/) or MultiAlin 
(http://multalin.toulouse.inra.fr/multalin/).The schematic representation of genomic sequences of 
fsta was design using the program Exon-Intron Graphic Maker (http://wormweb.org/exonintron). 
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3. Identification of novel targets of both dll4 and 
runx1, involved in HSC specification  
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3.1. Introduction 
Among the several signalling pathways important for the programming of arterial 
endothelium and/or HSC (Gering and Patient, 2005; Lawson et al., 2002; Wilkinson et al., 
2009), the Notch pathway has been extensively studied and has been well established that this 
pathway is involved in arterial development (Lawson et al., 2001) and HSC emergence (Burns 
et al., 2009; Gering and Patient, 2005). 
It was shown through the study of zebrafish embryos homozygous for a mutation in the 
ubiquitin ligase gene – mind bomb (mib) (which is required for Notch signalling), that Notch 
signalling is required for the generation of HSCs; these mutants lose runx1 and c-myb 
expression in the VDA at 1 dpf and rag1 in the thymus at 4 dpf (Burns et al., 2005; Gering and 
Patient, 2005, 2009). In addition to that, the requirement of Notch signalling in the generation of 
HSCs was also demonstrated through the analysis of zebrafish embryos treated with -
secretase inhibitor (DAPT), which has also shown a lack of runx1 expression (Gering and 
Patient, 2005, 2009). On the other hand, the analysis of mib mutant embryos and -secretase 
inhibitor treated embryos demonstrated that the requirement of Notch signalling in the primitive 
wave of haematopoiesis seems to be dispensable, since the primitive wave in these embryos 
was not affected (Burns et al., 2005; Gering and Patient, 2005). In general, the role of Notch 
signalling in inducing definitive haematopoiesis is well accepted. However, its role in HSC 
maintenance remains highly controversial (Bigas and Espinosa, 2012; Gering and Patient, 
2009; Loeffler et al., 2011). 
Although the requirement of Notch in haematopoiesis is well established and has been 
thoroughly described (Burns et al., 2009; Gering and Patient, 2005), there is still missing a 
detailed description about the ligands required. In zebrafish, two Notch ligands, dllc and dl4, are 
expressed in the DA (Lawson et al., 2001; Siekmann and Lawson, 2007). Recently, dllc 
together with dld (which is not expressed in the DA) has been described as a distinct non-cell-
autonomous combination required for HSC specification in zebrafish (Clements et al., 2011). On 
the other hand, knockdown of dll4 in zebrafish has previously only been described to cause an 
angiogenic (Hogan et al., 2009b; Leslie et al., 2007; Siekmann and Lawson, 2007) and 
lymphatic phenotype (Geudens et al., 2010). Both angiogenic and lymphatic phenotypes occur 
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later in development and the angiogenic phenotype which is observed earlier than the lymphatic 
phenotype, is not observed prior to 28-32 hpf (Geudens et al., 2010; Hogan et al., 2009b; Leslie 
et al., 2007). This indicates that when HSCs are first observed in the DA (24-27 hpf) the arterial 
programme is normal in dll4 morphants. The expression of Dll4 in mice has also been reported 
in the DA (Kumano et al., 2003; Robert-Moreno et al., 2005). However, mice carrying 
homozygous or heterozygous deletions of Dll4 die early in development due to a severe arterial 
phenotype (Gale et al., 2004; Krebs et al., 2004) thus not allowing the use of mice as a model to 
study the role of Dll4 in HSC emergence. 
Taking into account the late angiogenic phenotype of the dll4 zebrafish morphant (Leslie 
et al., 2007) and the impossibility of using mice to study the role of Dll4 in HSC emergence 
(Gale et al., 2004; Krebs et al., 2004), the zebrafish is thus considered a good model to 
investigate the role of the dll4/Notch pathway in HSC specification. 
Recent work performed in the lab, using a previously characterised splicing-morpholino 
spanning the splice donor sequence of exon 4 (Hogan et al., 2009b), has shown that 
knockdown of dll4 in the zebrafish leads to the loss of runx1 expression at 26 hpf in the VDA; 
which in turn results in HSC loss (Monteiro & Schneider, unpublished data). The loss in HSCs 
appears to not be transitory, since HSC specific markers at 36 hpf and progenitor markers of 
definitive lineages at 4 dpf were reduced (Figure 3.1; (Schneider, unpublished data)). These 
observations indicated that the lack of runx1 at 26 hpf results in dysfunctional HSCs, in the 
absence of dll4 (Schneider, unpublished data). 
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Figure 3.1- Knockdown of dll4 leads to a decrease of HSC and HSCs derivatives. Analysis by WISH 
of the expression of runx1, c-myb and ikaros in 36 hpf dll4 morphants and of rag1 in 4 dpf dll4 morphants; 
red arrows highlight the decreased expression of the markers analysed; (x/y), x - correspond to the 
number of embryos with the phenotype represented in the picture and y – total of embryos analysed. 
Figure adapted from (Schneider, unpublished data). 
 
To better understand the molecular mechanism by which Dll4 induces HSC 
specification, we aimed to identify novel targets of Dll4 that are important to establish HSC 
specification. For that, was performed an mRNA-seq experiment of dll4 morphants. Since, Dll4 
plays an important role in other biological process and additionally could be acting in HSC 
specification through various effectors; an mRNA-seq experiment of runx1 morphants was also 
performed to increase the possibility of identifies true targets of Dll4 in HSC specification. 
(Peterkin, Pinheiro & Schneider, unpublished data). 
 
3.1.1 mRNA-seq experiment 
In order to identify novel players involved in HSC specification, an mRNA-seq 
experiment of dll4 and runx1 zebrafish morphants at 26 hpf was performed previously in the lab 
(Figure 3.2.; (Peterkin, Pinheiro & Schneider, unpublished data)). 26 hpf was considered the 
ideal time in development for the identification of Dll4/Runx1 targets involved in HSC 
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specification since at this time the role of Dll4 is distinct from the later angiogenic role and 
because the circulation has started already (Peterkin, Pinheiro & Schneider, unpublished data). 
To minimise the dilution effect of the strong expression of runx1 and dll4 in the head, the 
embryos were dissected, the heads discarded and the trunks and tails used. These regions 
contain the DA, where HSCs emergence occurs and therefore the genes of interest should be 
enriched in this population. The mRNA-seq experiment and differential expression analysis was 
carried out by the High – Throughput Genomics Group at the Wellcome Trust Centre for Human 
Genetics, Churchill Hospital, University of Oxford.  
 
 
Figure 3.2 - Establishing dll4 and runx1 molecular targets in the zebrafish. mRNA-seq experimental 
setup: dll4 morpholino (dll4 MO4; Table 2.1) or runx1 morpholino (re6 MO; Table 2.1) were injected at the 
single cell stage. Trunk/tail regions were dissected for 200 embryos for each injection and 400 for the 
uninjected control at 26 hpf. Trunk/tails were collected for RNA extraction for each condition per 
experiment, in 4 replicates; MO – morphant. Figure from (Schneider, unpublished data). 
 
 The mRNA-seq experiment generated a list of raw data of approximately 30 000 genes. 
The analysis of this list was performed by excluding genes with less than 10 average reads per 
sample and genes which were not significantly differentially expressed across all biological 
replicates (High – Throughput Genomics Group at Wellcome Trust Centre for Human Genetics, 
Churchill Hospital, University of Oxford). The mRNA-seq experiment gave rise to a list of 1031 
differentially expressed genes (397 genes up - regulated and 634 down - regulated) for dll4 
morphant fish and a list of 2347 differentially expressed genes (1135 genes up - regulated and 
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1212 genes down - regulated) for runx1 morphant fish (Figure 3.3) (High – Throughput 
Genomics Group at Wellcome Trust Centre for Human Genetics, Churchill Hospital, University 
of Oxford). Surprisingly, since runx1 is supposed to be down-stream of dll4, the number of 
genes differentially expressed in the runx1 morphant list was more than the double the number 
of the dll4 morphant list.  
 
 
Figure 3.3 - Comparative analysis of the mRNA-seq experiment data. Analysis of the number of 
differentially expressed genes in both dll4 and runx1 morphants. Figure adapted from (Peterkin, 
Pinheiro & Schneider, unpublished data). 
 
By comparing the dll4 target genes to the runx1 target genes, common target genes 
were established (Schneider, unpublished data). As both runx1 and dll4 are co-expressed in the 
DA at this time point, the overlapping mRNA-seq target list is likely to be enriched for genes 
involved in HSC formation. This has resulted in a list of 808 common genes (Figure 3.3). These 
target genes then were subjected to Go-term analysis. The Go-term analysis was carried out by 
Dr Jie Zuo from Prof. Patient’s lab (WIMM, University of Oxford). 
 
3.1.2. GO-Term analysis  
HSC specification is tightly controlled at the transcription level (Wilkinson and Göttgens, 
2013). The study of these transcriptional regulators such as TFs, epigenetic modifiers and 
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signalling pathway effectors is very important and will give us a better understanding of HSC 
specification, emergence, expansion, homeostasis and differentiation (Wilkinson and Göttgens, 
2013).  
The TFs are one of the early “decision makers” in the cell; they have the ability to 
regulate gene expression and ultimately to implement cell fate. Their identification is very 
important in order to gain new leads on the molecular and cell biological processes concerning 
HSC specification (Tanaka et al., 2012). In this project, TF activity and signalling pathway 
effectors were chosen over other GO-terms. The genes were annotated with “transcription 
activator”, “transcription repressor”, “transcription regulator”, “DNA binding” and “signalling” 
(Zuo, unpublished data). 
Through Go-term analysis a list of 106 common target genes (20 genes up - regulated 
and 86 down - regulated) was obtained (Schneider & Zuo, unpublished data). The Go-term 
analysis data therefore appeared to provide a powerful filter by reducing candidate targets from 
over 800 to just 106 (Figure 3.4.).This analysis demonstrated strong enrichment for genes 
corresponding to “DNA binding” (approximately 58% of the common genes) and also a minor 
enrichment for genes corresponding to “transcription repressor” (approximately 2% of the 
common genes) (Figure 3.4.; (Zuo, unpublished data)). 
 
 
Figure 3.4 - Analysis of common targets of dll4 and runx1 by GO-term analysis. Through Go-term 
analysis the genes were annotated according to their transcription regulator activity with “transcription 
activator”, “transcription repressor”, “transcription regulator”, “DNA binding” or “ signalling”, identified as 
signalling pathway effectors. Figure adapted from (Peterkin, Pinheiro, Schneider & Zuo, unpublished data). 
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Interestingly, the common genes presented similar expression patterns in both 
morphants; in other words, a gene up or down - regulated in the dll4 morphant was also up or 
down - regulated in the runx1 morphant respectively (Table 3.1.; (Schneider, unpublished 
data)).  
 From the analysed list of the common target genes (Table 3.1.) the genes coding for 
epigenetic modifiers and duplicated genes, were not subjected to further analysis (Table 3.1. –
red arrows). Epigenetic modifiers, have an important role in the control of cellular transcription. 
However, the TFs are the master controllers that establish a crosstalk with epigenetic modifiers 
in order to regulate the transcription levels in the cell. Taking this into account we decided to not 
analyse them throughout this study. The genes that appeared duplicated in the genome of 
zebrafish were further analysed by bioinformatics tools. Only genes which could be designed 
primers to specific amplify the gene were evaluated in subsequent analysis.  
 From the 74 genes present in the common list, 46 were analysed in the present study, 
once 28 of the genes present in the list had been determined as epigenetic modifiers or multiple 
copies of the same gene (Table 3.1. – red arrows). 
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Table 3.1 – List of common target genes of both dll4 and runx1 morphants analysed in the present study. From (Peterkin, Pinheiro & Schneider, unpublished data). 
Associated Gene Name Ensembl id 
log2 Fold 
change 
runx1 list 
log2 Fold 
change 
dll4 list 
Transcription 
factor 
activity 
Transcription 
repressor 
activity 
Transcription 
activator 
activity 
Transcription 
regulator 
activity 
DNA 
binding 
Signalling 
  DOWN-REGULATED       
  total = 68       
sox21a ENSDARG00000031664 -1,31 -1,13       
neurod4 ENSDARG00000003469 -1,54 -0,95       
twist3 ENSDARG00000019646 -1,5 -1,48       
med18 ENSDARG00000041237 -1,21 -0,94       
olig4 ENSDARG00000052610 -1,05 -0,93       
taf5 ENSDARG00000018325 -1 -0,92       
ilf2 ENSDARG00000014591 -0,97 -1,05       
GTF2A1L ENSDARG00000063670 -0,8 -0,91       
MAPK12 (1 of 2) ENSDARG00000006409 -1,42 -0,85      BMP + vegf 
CR354435.1 ENSDARG00000051718 -1,77 -1,63       
 zgc:173552 ENSDARG00000070287 -1,75 -1,42       
 zgc:173552 ENSDARG00000051737 -1,75 -1,57       
CABZ01086354.1 ENSDARG00000076129 -1,75 -1,59       
 CR762436.3 ENSDARG00000074937 -1,7 -1,78       
 zgc:171759 ENSDARG00000075216 -1,67 -1,7       
 zgc:171759 ENSDARG00000034203 -1,64 -1,63       
wu:fe11b02 ENSDARG00000078724 -1,63 -1,65       
 zgc:171759 ENSDARG00000079909 -1,63 -1,78       
 CR354435.6 ENSDARG00000070297 -1,64 -1,8       
 zgc:171759 ENSDARG00000051778 -1,6 -1,5       
FP236812.2 ENSDARG00000075220 -1,59 -1,78       
 H2BFM ENSDARG00000074491 -1,56 -1,63       
 zgc:110434 ENSDARG00000051775 -1,5 -1,58       
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 zgc:173552 ENSDARG00000078294 -1,46 -1,67       
 zgc:173552 ENSDARG00000070282 -1,47 -1,51       
 zgc:171759 ENSDARG00000070289 -1,48 -1,61       
mcm3 ENSDARG00000024204 -1,49 -1,08       
 zgc:110434 ENSDARG00000051770 -1,43 -1,65       
zgc:171759 ENSDARG00000075482 -1,42 -1,62       
 zgc:171759 ENSDARG00000039547 -1,45 -1,47       
 hist2h3ca1 ENSDARG00000077587 -1,44 -1,61       
 zgc:171759 ENSDARG00000051726 -1,36 -1,64       
 CU302436.2 ENSDARG00000068928 -1,36 -1,54       
rfc3 ENSDARG00000055969 -1,35 -1,19       
zgc:110216 ENSDARG00000077456 -1,32 -1,49       
 CR354435.5 ENSDARG00000070286 -1,33 -1,38       
mcm5 ENSDARG00000019507 -1,33 -0,97       
mcm4 ENSDARG00000040041 -1,31 -1,03       
mcm7 ENSDARG00000035761 -1,33 -1,25       
 zgc:110434 ENSDARG00000070265 -1,3 -1,49       
mcm2 ENSDARG00000015911 -1,29 -1,04       
 HIST2H4B (1 of 7) ENSDARG00000070285 -1,25 -1,18       
 zgc:114037 ENSDARG00000051736 -1,25 -1,48       
 CR762436.4 ENSDARG00000075379 -1,25 -1,23       
rag2 ENSDARG00000052121 -1,26 -0,96       
 FP236812.1 ENSDARG00000074260 -1,26 -1,64       
polr2b ENSDARG00000012592 -1,26 -1,18       
Paics ENSDARG00000033539 -1,21 -0,94       
drap1 ENSDARG00000041203 -1,21 -1,19       
thap11 ENSDARG00000036055 -1,2 -1,07       
rfc4 ENSDARG00000042458 -1,18 -1,03       
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 h2afx ENSDARG00000029406 -1,2 -1,16       
 CU682604.1 ENSDARG00000068434 -1,17 -0,94       
Pcna ENSDARG00000054155 -1,11 -1,02       
mybl2 ENSDARG00000032264 -1,08 -0,89       
dnmt1 ENSDARG00000030756 -1,1 -0,83       
smarce1 ENSDARG00000016871 -1,08 -1,08       
tcf7l1a ENSDARG00000038159 -1,04 -1,19       
pold1 ENSDARG00000027689 -1,05 -0,92       
taf9 ENSDARG00000077870 -1,04 -0,93       
klf2b ENSDARG00000040432 -0,96 -0,86       
FBXL19 ENSDARG00000076929 -0,96 -1,06       
Terfa ENSDARG00000039302 -0,95 -0,95       
 HIST2H3A ENSDARG00000068941 -0,92 -1,16       
 msh6 ENSDARG00000011666 -0,92 -1,02       
smarcc1a ENSDARG00000017397 -0,92 -1,04       
arid2 ENSDARG00000007413 -0,81 -0,95       
sox9b ENSDARG00000043923 -0,7 -0,81       
Associated Gene Name Ensembl id 
log2 Fold 
change 
runx1 list 
log2 Fold 
change 
dll4 list 
Transcription 
factor 
activity 
Transcription 
repressor 
activity 
Transcription 
activator 
activity 
Transcription 
regulator 
activity 
DNA 
binding 
Signalling 
  UP-REGULATED       
  total = 6       
tcea3 ENSDARG00000004724 0,9 1,04       
rfx1a ENSDARG00000005883 1,08 1,08       
prox2 ENSDARG00000041952 2,29 1,29       
MRAS (1 of 2) ENSDARG00000062865 1,78 1,66      BMP 
Fsta ENSDARG00000052846 2,32 1,6      BMP 
dnmt5 ENSDARG00000057863 1,17 1,11       
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3.2. Best candidate genes important for HSC specification 
 In order to investigate the common target genes with a most likely role in HSC 
determination, the 46 genes were initially assessed by expression pattern analysis. Through the 
analysis of the expression patterns, we aimed to establish whether the target genes were 
expressed in tissues related to HSC emergence, such as the DA or tissues surrounding the DA. 
The expression pattern analysis was carried out by WISH on 26 hpf embryos; the same 
developmental time as the mRNA-seq experiment was conducted. In fact, this time point 
coincides with when the HSCs can first be detected by in situ hybridisation in the DA (between 
26 and 28 hpf) (Figure 1.3) (Bertrand et al., 2008; Bertrand et al., 2007; Kissa et al., 2008). 
For expression pattern analysis, gene specific probes were designed and constructed. 
The construction of each probe involved the design of a specific pair of primers, to amplify a 
product of approximately 1000 bp. In order to amplify by PCR the region of each interesting 
gene, total mRNA was extracted from whole Wt embryos at the same developmental stage as 
the mRNA-seq experiment (26 hpf). cDNA was synthesised and the PCR was performed using 
the designed primers (Table 2.3). Subsequently, the PCR product was cloned into an 
expression plasmid and sequenced in order to confirm the correct gene sequence and 
determine which restriction enzyme and RNA polymerase should be used to linearize the 
plasmid and synthesise the probe respectively (Figure 3.5).  
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It was not possible to produce successful probes for 9 genes; in which the cloning 
process was not successful. 
The general WISH analysis, allowed us to group the different analysed genes into five 
classes, based on the expression pattern: (1) neural tissues, (2) neural tissue and DA region, 
(3) broad, (4) somites and (5) eye (Figure 3.6 (B)). This analysis showed that approximately 
50% and 30% of the genes have either broad expression or are expressed in the neural tube 
and DA region, respectively, while several of them were exclusively expressed in neural tissues 
(Figure 3.6 (B)). 
Figure 3.5 – Schematic representation of the different steps 
involved to the analysis by WISH for each common target gene. (A) 
Initial step of RNA extraction and production of cDNA; (B) Cloning 
process; (C) Synthesis of the probe; (D) Analysis of gene expression by 
WISH using the probes produced in (C). 
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Figure 3.6 - Analysis of the expression patterns of mRNA-seq common target genes by WISH. (A) 
Analysis of expression pattern of runx1 and dll4 in 26hpf Wt embryos. Scheme adapted from (Monteiro, 
unpublished); (B) Graphic representation of the expression patterns obtained by the WISH screen of the 
common target genes of runx1 and dll4 morphants. 
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(1) Neural tissues – approximately 13% of the analysed genes had a specific expression in 
neural tissues, some specifically in the neural tube, such as sox21a, neurod4, MAPK12, 
dnmt1. All the genes were down-regulated in both morphants. However, the clear/clean 
expression pattern in the neural tissues, led us to exclude them from the most 
promising candidate genes having a possible role in HSC specification. Although, their 
possible involvement in HSCs cannot be completely discarded. Recently a functional 
interplay between the haematopoietic system and the sympathetic nervous system was 
described, showing that neuronal-mediated signalling from the developing sympathetic 
nervous system to the DA regulates haematopoietic stem cell emergence during 
embryogenesis (Fitch et al., 2012). This finding highlights the fact that HSC 
development needs to be viewed in the context of the development of other tissues 
(Fitch et al., 2012). On the other hand, it may reflect the importance of runx1 and dll4 
during neural specification (Benedito and Duarte, 2005; Kobayashi et al., 2012; 
Theriault et al., 2005; Zagami and Stifani, 2010) (Figure 3.7). 
 
 
Figure 3.7 – Common target genes with expression pattern in neural tissues. 
 
(2) Neural tissues and DA region – these embryos show an expression pattern in neural 
tissues, such as neural tube and/or individual neurons together with the expression on 
the region of the DA, although not specific to the DA. As already mentioned 
approximately 30% of the analysed genes had an expression pattern in neural tissue 
and the DA region. This expression pattern might possibly be the most interesting, due 
to their expression in the DA region. In this class, we observed the presence of several 
genes coding for conserved mini-chromosome maintenance proteins (MCM) which form 
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heterohexamers and play important roles in initiation and elongation during DNA 
replication (reviewed in (Ryu et al., 2005). In addition, other genes such as pcna and 
replication factor C, which are required for the elongation of primed DNA templates by 
DNA polymerase, had this expression pattern. These results indicated that both runx1 
and dl4 morphants possibly affect the cell-cycle. (Figure 3.8.). 
 
 
Figure 3.8 – Common target genes with expression patterns in neural tissues and the DA 
region (Red arrow indicates up-regulated gene in the morphants). 
 
(3) Broad – the majority (50%) of the common genes had broad expression, reflecting 
possibly the general and pivotal role of these genes in the cell. Due to their broad 
expression, we cannot rule out expression in the DA; further analysis of gene 
expression on sections would be required. 
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Figure 3.9 – Common target genes with broad expression pattern (Red arrows indicate up-
regulated genes in the morphants).  
 
(4) Somites – tcea3 and follistatin a (fsta) are expressed in the somites. fsta is expressed in the 
ventral region of the somites, which is adjacent to the DA region and is known to play a role 
in setting up signals required for HSC emergence (Figure 3.10 ; (Clements et al., 2011)). 
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Figure 3.10  – Common target genes with expression patterns in the somites (Red arrows 
indicate up-regulated genes in the morphants). 
 
(5) Eye – prox2 is specifically expressed in the eye (Figure 3.11 (A)). As already 
described, the mRNA–seq experiment was performed using only the tail and trunk 
region of the fish. Thus, a further analysis of this gene would be required in order to 
understand whether ectopic expression is observed in the tail/trunk of the morphants. 
However, the analysis of the expression pattern of prox2 in the morphants revealed a 
broad expression in the ventral posterior region of the tail, decreasing the likely 
importance of this gene in HSC emergence (Figure 3.11 (B)). 
 
Figure 3.11 – Analysis of the expression pattern of the common target gene prox2. (A) 
Expression pattern in Wt zebrafish at 26 hpf (Red arrow indicates up-regulated genes in the 
morphants); (B) Expression pattern in dll4 morphants at 26 hpf.  
 
Through the analysis of the expression patterns by WISH, we did not find any gene 
specifically expressed in the DA region. And so we were not able to identify which Dll4 and 
Runx1 target genes are most likely to play a role in HSC development. However, the expression 
patterns classified as neural tube and DA region and broad are likely to be the most promising 
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ones. Taking into account these results, and in order to take advantage of the screen 
information, we looked carefully into each gene analysing its possible roles through the 
annotated result and literature review. We were looking for a relationship between the analysed 
genes and known players in HSC programming 
During the literature search, several genes came to our attention, including: twist3, rag2 
and zgc:110216. The recent work of Cannon et al. has shown that the transcripts of twist3, rag2 
and zgc:110216 (genes present in our list) are enriched threefold or more in the blood and/or 
vascular endothelial cells compared with the rest of the embryo at 26 – 28 hpf (the same time 
period of the mRNA-seq experiment) (Cannon et al., 2013). In addition to these genes, MRAS 
has also been annotated as an important player in the BMP signalling. The importance of BMP 
signalling in HSC specification is well established (Wilkinson et al., 2009). Finally, sox9b and 
fsta have also come to our attention. Dalcq and colleagues have suggested that sox9b together 
with runx3, EGR1 and fsta form a regulatory cascade required to modulate BMP-signalling 
during cranial development in zebrafish (Figure 3.12.; (Dalcq et al., 2012)). Indeed, fsta was 
annotated as a signalling molecule important in BMP pathway (Go-term analysis; Zuo, 
unpublished data). 
In the possible network model described by Dalcq and colleagues, in Wt embryos, 
pharyngeal endoderm expresses a regulatory cascade composed of three TFs, runx3, erg1 and 
sox9b, which down-regulates fsta expression; this down-regulation of fsta allows the binding of 
BMP ligands to their receptor and consequently induces runx2b expression in cranial neural 
crest cells (Figure 3.12 (A -1.); (Dalcq et al., 2012)). However embryos lacking any of the 
runx3-erg1-sox9b cascade have an overexpression of fsta and consequently the BMP ligands 
are unable to bind their receptor and so there is no BMP signalling in cranial neural crest cells 
and no runx2 expression (Figure 3.12 (A -2.); (Dalcq et al., 2012)). 
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Figure 3.12 – Schematic network of sox9b and fsta. (A) Regulatory cascade required to modulate BMP-
signalling during cranial cartilage development in zebrafish – Signalling model in Wt embryos (1.) and in 
embryos lacking the endodermal regulatory cascade (2.) Adapted from (Dalcq et al., 2012); (B) Scheme of 
a possible network to induce HSCs. 
 
The mRNA-seq analysis showed that inhibition of dll4 or runx1 signalling leads to a 
decrease of sox9b expression and an increase of fsta expression (Table 3.1; Peterkin, Pinheiro, 
& Schneider, unpublished data). This is in accordance with the signal model described by Dalcq 
et al. In addition, it is well established that Follistatin a is a signalling molecule important for 
BMP signalling, it is known as an antagonist of BMP (Bauer et al., 1998). Moreover it has been 
described that inputs from BMP signalling are required to correctly programme the first HSCs 
(Wilkinson et al., 2009). 
Altogether, this makes sox9b and fsta good candidates to play an important role in HSC 
emergence (Figure 3.12). 
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3.3. follistatin a is up – regulated and sox9b is down - regulated in 
both dll4 and runx1 morphants. 
To validate the results of the mRNA-seq for fsta and sox9b, qRT-PCR was performed 
by using mRNA from tails and trunks of zebrafish embryos at 26 hpf of both dll4 and runx1 
morphants (experimental procedure was carried out by Janina Schneider from Prof. Patient’s 
lab (WIMM, University of Oxford)). The qRT-PCR was performed using specific primers for fsta 
and sox9b (Table 2.3) and g6ph was used as a housekeeping gene for normalisation. This 
analysis was performed using two different morphants of runx1, re6 MO (the morpholino used in 
the mRNA-seq experiment) and re1 MO (used as a known null-inducing positive control) and 
one morphant of dll4 (dll4 MO4).  
Our results showed an up-regulation of fsta expression levels in both dll4 and runx1 
morphants (Figure 3.13 (A)). runx1 morphant: re1 MO –  4.4 fold change ± 0.048 (P < 0.001); 
re6 MO – 5.5 fold change ± 0.419 (P < 0.001); dll4 morphant: dll4 MO4 – 2.7 fold change ± 
0.232 (P < 0.001). The results obtained reproduce one biological sample (with three technical 
replicates) but was reproduced in a second biological sample. Error bars are representative of 
standard deviations from three technical replicates. Moreover, WISH analysis also 
demonstrated an up-regulation of fsta expression in both runx1 and dll4 morphants. In the dll4 
morphants, 58 out of 101 embryos had fsta gene expression increased when compared with 
Wt. For runx1 morphants, 16 out of 19 embryos had fsta expression increased when compared 
with Wt (Figure 3.13 (B)).  
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Figure 3.13 –. Analysis of the levels of fsta expression in both dll4 and runx1 morphants. (A) 
Quantitative RT-PCR analysis of fsta expression in both dll4 (dll4 MO4) and runx1 (re1 MO and re6 MO) 
morphants. Error bars are representative of the standard error from three technical replicates; ** P < 0.001. 
 (B) WISH analysis of fsta expression in both dll4 (dll4 MO4) and runx1 (re6 MO) morphants.  
 
Interestingly, and in according with the mRNA-seq experiment, the analysis of sox9b 
expression by qRT-PCR in both morphants has revealed down-regulation of sox9b expression 
levels. Nevertheless, the fold change observed for both morphants was not significantly different 
(runx1 morphant: re1 MO – 0.9 fold change ± 0.046 (P < 0.01); re6 MO – 0.7 fold change ± 
0.011 (P < 0.001); dll4 morphant: dll4 MO4 – 0.8 fold change ± 0.034 (P < 0.001)) (Figure 3.14 
(A)). Analysis by WISH for sox9b in dll4 morphants was performed however its broad 
expression made the analysis very difficult. We conclude that WISH is not sensitive enough to 
determine changes in the expression levels of sox9b (Figure 3.14 (B)). 
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Figure 3.14 – Analysis of the levels of sox9b expression in both dll4 and runx1 morphants. (A) 
Quantitative RT-PCR analysis of fsta expression in both dll4 (dll4 MO4) and runx1 (re1 MO and re6 MO) 
morphants. Error bars are representative of the standard error from three technical replicates; * P < 0.01 ** 
P < 0.001. (B) WISH analysis of fsta expression in dll4 morphants (dll4 MO4). 
 
Together these results provided additional support for the validity of the mRNA-seq 
experiment data and identified fsta as a more promising candidate target gene compared to 
sox9b. To further explore the potential role of fsta in HSC specification, we next performed a 
knockdown experiment (section 4. of this thesis).  
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3.4. Discussion 
 Here, through the analysis of expression patterns of the previously identified common 
target genes in both dll4 and runx1 morphant lists by WISH, and a careful literature review of 
each gene, we identified some possible candidate genes including: twist 3, rag2, zgc:110216, 
MRAS, sox9b and fsta. However we decided to further explore the potential role of fsta in HSC 
specification given its role in antagonizing the BMP pathway, which in turn is required for HSC 
specification (Bauer et al., 1998; Wilkinson et al., 2009). Curiously, we detected more significant 
differential expression levels of fsta in both morphants when compared with sox9b expression 
pattern, which in turn was specific and stronger in the ventral region of the somites, adjacent do 
the DA region. 
 Furthermore, we concluded that using WISH as a methodology to address the question 
whether target genes obtained from the mRNA-seq experiment have a possible role in the 
haematopoietic process, is possibly not the most informative methodology. As an alternative 
approach, we could have done a morpholino screen instead of WISH but this would have been 
prohibitively expensive. 
Nevertheless, through this screen, we were able to conclude that neural signalling is 
being affected in both morphants, since several of the target genes had an expression pattern in 
neural tissues. However, as we already mentioned such pathways might be related to HSC 
development; both morphants possibly are affecting the cell-cycle, since several cell-cycle 
related TFs were affected in both morphants. It will be important to gain insight into these topics 
and their possible relation to HSCs.  
The up-regulation of the mRNA expression levels of fsta in both dll4 and runx1 
morphants (Figure 3.15 (A)) and the expression pattern of fsta in the ventral region of the 
somites together with the Follistatin a role as an antagonist of BMP (Figure 3.15 (B. i.); (Bauer 
et al., 1998)) and the requirement of BMP in HSC specification, previously described (Figure 
3.15 (B. ii.); (Wilkinson et al., 2009)), make fsta an interesting candidate gene for further 
exploration of its potential role in HSC development. 
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Figure 3.15 – Schematic hypothesis of the role of fsta in HSC emergence. (A) Expression levels of 
fsta in both dll4 and runx1 morphants obtained by mRNA-seq (Peterkin, Pinheiro & Schneider, 
unpublished data). (B) Literature review observations: i. Follistatin a is an antagonist of BMP (Bauer et al., 
1998); ii. BMP is required for HSC specification (Wilkinson et al., 2009). (C) Hypothesis of the role of fsta in 
HSC emergence; Fsta – Follistatin a. 
 
Thereby to further explore the potential role in HSC specification of Follistatin a we 
decided to perform a functional analysis by knockdown of fsta using a morpholino (section 4. of 
this thesis). 
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4. Role of follistatin a in regulating HSC specification 
during zebrafish development.  
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4.1. Introduction 
Follistatin, a secreted glycoprotein, was originally described as an inhibitor of activins by 
Nakamura and colleagues (Nakamura et al., 1990). This protein binds directly to activins with 
high affinity, and functions as an activin antagonist, preventing the binding of activins to their 
transmembrane receptors (de Winter et al., 1996). In addition, it has been reported that 
Follistatin also binds with lower affinity to several other members of the TGF-β superfamily, 
modulating their actions. These include myostatin, growth differentiation factor-9 (GDF-9), 
TGFβ3 and BMPs, including BMPs 2, 4, 6, 7, 11 and 15 (Amthor et al., 2002; de Kretser et al., 
2012; Gamer et al., 1999; Glister et al., 2004; Iemura et al., 1998; Li et al., 2011; Otsuka et al., 
2001; Thompson et al., 2005; Zong et al., 2013). Although Follistatin interacts directly with BMP, 
it does not prevent the ligand binding to its own receptor (Iemura et al., 1998). However, it has 
been suggested that conformational changes of BMP caused by Follistatin binding prevent 
receptor activation. The interaction between Follistatin and BMP seems to be subtype specific; 
where distinct affinities have been observed for the different BMPs (Iemura et al., 1998).  
Mammals and birds have single copies of Follistatin gene while zebrafish, presumably 
as a result of an ancient duplication of the genome, has two orthologues of the mammalian 
Follistatin gene: follistatin a (fsta) (Gene ID: ENSDARG00000052846) and follistatin b (fstb) 
(Gene ID: ENSDARG00000057992). Nevertheless fsta is more closely related to its mammalian 
orthologues than fstb (Dal-Pra et al., 2006; Macqueen and Johnston, 2008). Indeed, alignment 
of vertebrate orthologues of Follistatin revealed a high degree of conservation at the protein 
level (Figure 4.1.). At the protein level, Follistatin a shares around 70%-75% identity with 
human and mouse Follistatin, whereas Follistatin b shares around 66-68% identity with its 
human and mouse orthologues (Figure 4.1.).  
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Figure 4.1 –.Bioinformatic analysis of Follistatin protein. (A) Follistatin protein 
sequence alignment of human (GenBank: AAH04107.1), mouse (GenBank: 
CAA82648.1) and zebrafish (fsta-002 ENSDART00000146237; fsta -201 
ENSDART00000051065; fstb-001 ENSDART00000080772; fstb-
ENSDART00000110443) using MultiAlin (http://multalin.toulouse.inra.fr/multalin/). Red-
High consensus; Blue-Low consensus; Black-Neutral; (B) Scores of identity between 
human, mouse and zebrafish follistatin protein using clustalW2 
(www.ebi.ac.uk/Tools/msa/clustalw2/.  
A 
B 
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Similarly with what happens in higher vertebrates, two different variants of fsta 
transcripts have been identiﬁed in zebrafish: a longer variant, fsta-201, with 324 amino acids 
(Trancript ID: ENSDART00000146237) and a truncated variant, fsta-001, with 322 amino acids 
(Trancript ID: ENSDART00000051065), which differ in the last 11 amino acids at the carboxyl 
terminus (Bauer et al., 1998) (Figure 4.1.). The N-terminal region of zebrafish Follistatin 
contains a putative signal peptide consisting of 2 basic amino acids (KR) (which indicates that 
Follistatin is a secreted protein), a central hydrophobic region (ILLLFWLCYLI), and a more polar 
region (EDQKVQ) anterior to the putative cleaving site (A/ G) which are responsible for the 
binding of the protein to their targets (von Heijne, 1986; Keutmann et al., 2004). 
Taking into account the ability of Follistatin to bind several members of the TGF-β 
superfamily, many studies have been performed to investigate the role of Follistatin in different 
biological processes. In this regard, it has been reported that Follistatin exerts a pleiotropic 
effect, directly or indirectly influencing a wide range of biological effects (Amthor et al., 2002; 
Phillips and de Kretser, 1998; Zong et al., 2013).  
It has been previously shown that Follistatin knockout mice survive to birth, but exhibit 
defects in size, skeletal muscle development; dying shortly after delivery (Matzuk et al., 1995). 
Therefore, zebrafish has been used as a model to study several processes of the development 
in which fsta plays a role (Bauer et al., 1998; Dalcq et al., 2012; Li et al., 2011). However, 
studies revealing the importance of fsta in the development of HSCs were never described. 
Initially, Follistatin was reported to play a key role in the regulation of gonadal 
development and oocyte maturation, since it is a specific inhibitor of the biosynthesis and 
secretion of pituitary follicle stimulating hormone (fsh) (reviewed in (Phillips and de Kretser, 
1998)). Later, several other functions of fsta in zebrafish have been described. The activation of 
fsta gene was shown to induce neural specification (Hemmati-Brivanlou et al., 1994; Ragland 
and Raible, 2004) and to inhibit BMP signalling (Bauer et al., 1998; Dal-Pra et al., 2006). 
However, it is not involved in organizer function or early phases of dorso/ventral patterning 
normally regulated by BMP, since its expression occurs too late during embryonic development 
to play a major role in dorsal/ventral axis formation in zebrafish (Bauer et al., 1998; Dal-Pra et 
al., 2006). Furthermore, Follistatin was shown to be important during ectopic otic tissue 
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formation (Kwon and Riley, 2009), regulation of myogenesis (Li et al., 2011) and development 
of cranial cartilage in zebrafish (Dalcq et al., 2012). 
In the present study the role of fsta in haematopoiesis during the development of 
zebrafish was explored. 
 
4.2. Expression of fsta in zebrafish embryos 
In contrast to their homologues in Xenopus embryos, fsta transcripts were not detected 
prior to the onset of gastrulation during zebrafish early embryogenesis (Bauer et al., 1998). In 
fact, both WISH and RT-PCR analyses have shown that fsta expression is initially detected at 
50% epiboly and observed throughout later stages, with a maximum value at 8 and 15 somites 
stages (Bauer et al., 1998; Thisse et al., 2001; Zong et al., 2013). 
In the present study, we investigated the spatial and temporal patterns of fsta 
expression in comparison to runx1 and dll4 by WISH at five different time points, corresponding 
to: 50% and 80% epiboly stage, 13 somites, 20 somites and 26 hpf (Figure 4.2 and Figure 4.3). 
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Figure 4.2 –. Time course of runx1,dll4 and fsta expression pattern in wild type embryos. Expression 
pattern of runx1,dll4 and fsta in zebrafish embryos at indicated stages (50% epiboly – 5.3 hpf; 80% epiboly 
- 8.5 hpf; 13 somites – 15 hpf, 20 somites – 19 hpf) detected by WISH. 
 
WISH revealed an initial expression of fsta and runx1 transcripts at 50% epiboly, while 
dll4 transcripts expression was first observed at 13 somites (Figure 4.2). The fact that dll4 
expression does not start until around 13 somites supports the idea that the up-regulation of 
expression of fsta in both dll4 and runx1 morphants was not a consequence of an early 
phenotype of the morphants.  
At the onset of gastrulation, runx1 and fsta RNA are expressed in mesoderm (red 
arrows). During gastrulation, at 80% epiboly stage, it was possible to observe that fsta 
expression was in presumptive cephalic mesendoderm (red arrows), but it was excluded from 
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the medial region (from notochord precursors) as previously described (Figure 4.2) (Dal-Pra et 
al., 2006). At later stages, such as 13 somites, 20 somites and 26 hpf, fsta expression was 
visualized in the head, eyes and somites regions (Figure 4.2 and 4.3). At 13 somites stage, 
runx1 was expressed in the lateral plate mesoderm and in Rohon-Beard cells (blue arrows) in 
developing haematopoietic and neuronal cells respectively. Later at 26 hpf, runx1 has a strong 
expression in the DA, as previously described (Kalev-Zylinska et al., 2002). dll4 was initially 
expressed at 13 somites in a diffuse way, while later becomes specific to the DA, the 
intersomitic vessels and to some neurons (Leslie et al., 2007). 
In order to more accurately determine the locations of runx1, dll4 and fsta expression at 
the time point when HSCs become detected by WISH (same time point used in mRNA-seq 
experiment), transverse sections through the trunk/tail of 26 hpf embryos were carried out 
(Figure 4.3 ). These sections were executed using WISH-analysed embryos for runx1, dll4 and 
fsta. In the transverse sections of the embryos expressing runx1, positive cells for runx1 were 
localized at the the VDA region; exactly where occurs emergence of HSCs (Burns et al., 2002; 
Kalev-Zylinska et al., 2002; North et al., 1999). As previously described (Leslie et al., 2007), 
analysis of dll4 expression in sectioned embryos, revealed a strong expression pattern in the 
DA and also in intersomitic vessels. The expression of fsta, in turn, was observed in a diffuse 
way along the somites, but most strongly at the ventral region of the somites and in neural 
tissue. It is important to remember that Follistatin a is a soluble factor which is secreted (Phillips 
and de Kretser, 1998). Therefore, its presence at the ventral region of the somites, which is 
physically close to the DA, suggests that protein could be a player of the HSC emergence. 
Thus, both the biological activity and the time and place of expression in the embryo coincide 
with the HSC emergence activity previously defined (Burns et al., 2002; Gering and Patient, 
2005). Altogether, these observations strongly suggest a possible role for fsta in HSC 
emergence. In order to study this hypothesis we performed a knockdown of fsta in zebrafish 
using antisense morpholino oligonucleotides. 
 
 
82 
 
Figure 4.3 – Analysis of runx1,dll4 and fsta expression patterns in transverse sections of the trunk 
of 26 hpf wild type embryos. (A) Scheme of a cross-section of the trunk of a zebrafish embryo. Scheme 
adapted from (Medvinsky et al., 2011); (B) Expression pattern of runx1, dll4 and fsta in the trunk of 26 hpf 
Wt embryo; lateral view and transverse section of the trunk. Expression of runx1 in the VDA; expression of 
dll4 in the DA and intersomitic vessels; expression of fsta in the ventral region of the somites and in the 
neural tube. 
 
 
4.3. fsta knockdown during zebrafish embryonic development 
To clarify whether fsta gene is important or required for HSC development, we 
knockdown fsta expression in zebrafish embryos using a previously characterized antisense 
splice blocking morpholino. fsta MO1 spans the splice donor sequence of exon 2 (Figure 4.4 
;(Tsukada, 2010)).  
 
A 
B 
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Figure 4.4 –. Schematic representation of the design of fsta morpholino. Genomic structures of both 
fsta-201 and fsta-001 transcripts, constituted by five and six exons respectively (black boxes) 
(http://wormweb.org/exonintron), with the binding place of fsta MO1 and of the primers used to test the fsta 
MO1 by RT-PCR (F3 and R3). 
 
The morpholino used in the present study have been previously described, however we 
performed a titration between 5 ng/nL to 40 ng/nL. Was injected 0.5 nL of morpholino per 
embryo with the objective of determining the ideal working concentration. This was determined 
to be in the range of 5 to 10ng/nl, where the embryos do not present any apparent 
morphological defect and the circulation and heart beat were normal (Figure 4.5).  
 
 
Figure 4.5 – Phenotypes of embryos injected with different concentrations of fsta MO1. Lateral view 
of live 26 hpf embryos injected with 15, 20, 30 and 40 ng of fsta MO1. Embryos injected with high 
concentrations of fsta MO1 [20-40 ng/nL] (injected 0.5 nL) start to display morphology defects in the tail, 
reduced eyes and brain necrosis.  
 
To investigate whether the splice blocking morpholino interfere with the normal fsta pre-
mRNA splicing and subsequent translation, RT-PCR analysis and western blot were performed 
using anti-Follistatin a antibody for 36 hpf and/or 4 dpf embryos injected with fsta MO1. These 
analyses revealed an abolition of Follistatin a protein expression (Figure 4.6 C) but formation of 
two aberrant forms of fsta splicing in the morphants compared to the Wt (Figure 4.6 A - red 
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arrows). Sequencing of these two additional products revealed an inclusion of 36 nucleotides of 
intron 2, due to the use of a cryptic splice site, for the larger transcript (Figure 4.6 B), upper red 
arrow) which caused an in-frame insertion resulting in a larger protein. This likely affect normal 
function of the protein, as the N-terminal domain and the first two domains of the protein will not 
be able to rearranged correctly for binding and neutralization of its targets (Keutmann et al., 
2004a) (Figure 4.6 C). The sequencing of the smaller transcript, in turn, has demonstrated the 
skipping of exon 2 and part of exon 3, leading to the expression of a completely different 
protein, which most likely will be degraded (Figure 4.6 B) - lower red arrow). 
 
 Figure 4.6 – fsta gene expression is knowcked down by fsta MO1 injection. (A) RT-PCR using 
primers in exons 2 and 3 on cDNA made from total RNA isolated from Wt and morphant embryos (7.5 ng 
fsta MO1) at 36 hpf and 4 dpf, revealed the formation of alternative splice products following fsta MO1 
injection (red arrows), in addition to Wt product (blue arrow). ef1α (692 bp) was used as an internal loading 
control. Decreasing amounts of cDNA were analysed; (B) DNA sequence of the alternative splice product 
((A) upper red arrow) showed a inclusion of 12 aminoacids, which caused an in-frame insertion resulting in 
a larger protein; (C) The expression levels of Follistatin a were measured by western blot of control (Wt) 
and fsta morphants (7.5 ng fsta MO1) at 36 hpf. β-actin was used as loading control. Anti-fsta – Antibody 
anti-Follistatin a; Anti-bactin - Antibody anti-β-actin. 
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4.4. Loss of fsta gene increases HSC numbers 
In the previous chapter, we found that fsta expression was up-regulated in both dll4 and 
runx1 morphants, which suggests a potential role for Follistatin a in the regulation of HSCs 
development. In order to clarify the precise function of this glycoprotein in haematopoiesis 
process, we examined the formation of definitive HSCs in fsta morphants. Initially we analysed 
the expression of transcriptional regulators of HSC specification: the genes runx1, c-myb, and 
ikaros, which provide the earliest established markers of definitive HSCs in zebrafish (Kalev-
Zylinska et al., 2002; Thompson et al., 1998; Willett et al., 2001; Zhang et al., 2011). As mention 
above, runx1 morphants at 26 hpf have an increased expression of fsta, suggesting that fsta 
acts down-stream of runx1 at this developmental period. Although runx1 is required for HSC 
emergence, this TF also plays a pivotal role in the survival of these cells. Indeed, it seems that 
other factors, for example blood flow, are required by runx1 in the early maintenance of HSCs 
(Lam et al., 2010; North et al., 2009). Taking this into account, we decided to also analyse runx1 
expression in fsta morphants. By WISH analysis, we found that, in morphants at 36 hpf, the 
expression levels of c-myb and runx1 increased in the VDA (Figure 4.7). We also observed an 
increase of the expression of ikaros, a DNA-binding protein required for lymphoid development 
in the same region and time-point (Figure 4.7) (Georgopoulos et al., 1997) .The results here 
represented correspond to one experiment. 
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Figure 4.7 – Follistatin a is an important modulator of HSC development. WISH analysis of runx1, c-
myb, and ikaros at 36 hpf in Wt and fsta morphant of zebrafish embryos – increased expression of all the 
markers in the morphants comparing with Wt ; (x/y), x - corresponds to the number of embryos with the 
phenotype represented in the picture and y – total number of embryos analysed. Scheme from (Monteiro, 
unpublished). 
 
Consistent with our hypothesis, we demonstrated that inactivation of fsta gene causes 
an increase of definitive progenitors of HSCs. These results provide strong evidence that fsta is 
a negative regulator of HSC development.  
 
4.5. Increased thymus seeding of HSCs in fsta morphants 
In order to clarify whether the morpholino-induced increase of HSC progenitors in the 
DA truly reflected an increase of definitive HSCs, we decided to analyse the thymocytes, the 
first mature product of the adult blood stem cell easily identified in zebrafish embryos (Burns et 
al., 2005). To clarify if T cell progenitor population are differentially regulated by fsta, we 
assessed the effect of fsta silencing on development of T cell progeny in morphants at 4 dpf by 
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WISH, using probes for rag1, a lymphocyte-specific nuclease required for T cell antigen 
receptor (TCR) gene rearrangement (Langenau et al., 2004; Willett et al., 1997) and foxn1, a TF 
required for generation of thymic epithelium (Su et al., 2003). We also analysed the 
development of T cells labbeled to lck: EGFP transgene at 4 dpf. lck, is a tyrosine kinase 
required for T cell development (Figure 4.8) (Langenau et al., 2004).  
 
Figure 4.8 – Loss of fsta increases thymic seeding of HSCs. (A) Schematic representation of the 
thymus (blue) at 4 dpf zebrafish embryo. Scheme from (Schneider, unpublished); (B) At 4 dpf rag1 and 
foxn1 are expressed in the thymus; the expression of rag1 and foxn1 in the morphants are increased 
comparing to Wt (ventral view). (C) Knockdown of fsta in Tg (lck:EGFP) increase the GFP-marked T cell 
progenitors comparing to uninjected embryos at 4 dpf (ventral and dorsal view); (x/y), x - correspond to the 
number of embryos with the phenotype represented in the picture and y – total of embryos analysed. 
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 WISH using a rag1 probe, which labels T lineage progenitors, revealed that knockdown 
of fsta increases the seeding of the thymus. In fact, at 4 dpf rag1
+ 
cells were found in the thymus 
at higher levels compared with Wt embryos (Figure 4.8 B). These results have been confirmed 
by the observation of increased levels of GFP-marked T cell progenitors in Tg (lck:EGFP) 
zebrafish embryos injected with fsta MO1, when compared with uninjected embryos (Figure 4.8 
C). Additionally, analysis of the foxn1 expression levels in the thymic epithelium showed that 
this gene was still unaffected, thus suggesting that the increase of rag1 expression might result 
from an increase of T-cell numbers, and not from a decrease in thymus size. 
  
4.6. Myeloid and erythroid lineages are affected in fsta knockdown 
embryos  
HSCs give rise to myeloid as well as erythroid cells in the CHT. In order to determine if 
the myeloid lineage was affected in the fsta morphant, we analysed the expression of the 
myeloid marker, myeloid-specific peroxidase (mpx; granulocytes (Bennett et al., 2001)) at 4 dpf. 
Notably, 4 dpf mpx
+
 cells were found at higher levels in the fsta morphant CHT when compared 
with Wt (Figure 4.9 B), suggesting that definitive myeloid differentiation is increased in the 
absence of fsta.  
To clarify whether the erythroid lineage was indeed impaired in these conditions, we 
analysed by WISH the expression of erythroid derivatives, hbbe1.1 (Brownlie et al., 2003; 
Quinkertz and Campos-Ortega, 1999), in the CHT of 4 dpf morphants. Curiously, hbbe1.1 
+
 cells 
were found in the fsta morphant CHT at lower levels, when compared with Wt (Figure 4.9 B). In 
addition, the expression of definitive erythroid progenitors CD41 at 4 dpf in the CHT was 
evaluated, through the use of the transgenic line Tg (CD41:EGFP) (Lin et al., 2005), where GFP 
is under the control of CD41 (also known as itga2b). The knockdown of fsta in Tg 
(CD41:EGFP), allowed us to observe a higher accumulation of CD41
+
 cells in the CHT at 4 dpf, 
when compared with Tg (CD41:EGFP) uninjected (Figure 4.9 C). These results are intriguing 
and further investigation is required to confirm this preliminary data. However these results 
could indicate that fsta plays different roles in HSC specification; being either a positive 
regulator of hbbe1.1
+
cells and a negative regulator of CD41
+
cells.  
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Figure 4.9 – Analysis of myeloid and erythroid markers in fsta knockdown embryos. (A) Schematic 
representation of zebrafish embryo at 4 dpf with the highlight to the CHT. Scheme adapted from (Monteiro 
et al., 2011); (B) Analysis by WISH of the increased expression levels of mpx and decreased expression 
levels of hbbe1.1 in the fsta morphants comparing with Wt. (C) knockdown of fsta in Tg (CD41:EGFP) 
increase the GFP-marked CD41 cells comparing to uninjected embryos at 4 dpf in the CHT; (x/y), x - 
correspond to the number of embryos with the phenotype represented in the picture and y – total of 
embryos analysed. 
 
Thus, our results provided evidence that fsta is required for specification of the definitive 
HSC fate. However, further analyses of this knockdown are needed for a better understanding 
of fsta role. 
As HSC emergence and endothelial specification are intimately linked, potential roles of 
fsta in vascular development was also investigated. 
 
 
90 
4.7. Follistatin a plays a role in the modulation of HSC and 
endothelial programming 
Blood programming is strongly related with endothelial programming. Indeed, both 
lineages share the common progenitor cells, haemangioblasts, up to the emergence of HSC 
from the haemogenic endothelium (reviewed in (Dzierzak and Speck, 2008). To clarify whether 
the increased HSC number in fsta morphants was specific to the HSC rather than due to the 
alteration of endothelial programming, we examined endothelial programming under fsta 
knockdown. For that, the endothelial marker kdrl (the Vegf receptor II) was evaluated by WISH. 
Although we observed a slight increase of kdrl expression in the PCV region, WISH 
analysis of kdrl at 36 hpf showed that ISVs develop apparently normally in fsta morphants 
(Figure 4.10 (A)). To further dissect the molecular mechanism by this happens we followed the 
endothelial programming in a transgenic line expressing GFP under the control of the kdrl 
promoter (Hogan et al., 2009a). We have used a double transgenic line Tg 
(kdrl:GFP/gata1:DsRed) (Jin et al., 2005; Traver et al., 2003) in which fsta MO1 was injected at 
the one cell stage. In both injected and uninjected embryos, angiogenesis from the DA 
appeared normal; where the sprouting from the DA is clearly visible along with the initial 
formation of the DLAV. The development of the CHT also involves angiogenesis, and in fact we 
observed an increase of the vein sprouts in the CHT at 4 dpf in embryos injected with the fsta 
MO1 (Figure 4.10 (B)).  
Additionally, the number of gata1
+ 
cells in the injected embryos with fsta MO1 seems 
increased at 4 dpf, when compared with uninjected embryos (Figure 4.10). Altogether, these 
results suggest that fsta is also an important regulator of the blood and venous programming. 
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Figure 4.10 – fsta play a role in the modulation of the HSCs and endothelial programming. (A) 
Analysis of kdrl expression by WISH at 36 hpf. Scheme from (Monteiro, unpublished); (B) Analysis of Tg 
(kdrl:GFP/ gata1:DsRed), first panel -lower magnification and second panel – higher magnification; (x/y), x 
- correspond to the number of embryos with the phenotype represented in the picture and y – total of 
embryos analysed. Scheme adapted from (Monteiro et al., 2011).  
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4.8. Discussion 
In the previous chapter, we identified fsta as a potential candidate gene required for 
HSCs specification. In this chapter, we investigated the role of fsta in HSC emergence, 
concluding that loss of fsta leads to an increase of HSC numbers. Additionally we also observed 
that the loss of fsta leads to an increase in vein sprouting. Our data provide the first evidence of 
a role of fsta in HSC and venous specification. 
Specifically, the results presented here suggest that signalling by fsta is required to 
restrict HSC specification. In the angiogenesis context, fsta seems to forms part of an essential 
mechanism to keep vein angiogenesis under proper control.  
Taking into account that morpholinos can lead to off-target effects, which in turn can lead 
to a misinterpretation of potential phenotypes, it would be important to control potential  
artefacts in future experiments (Eisen and Smith, 2008). For example, the use of a second 
morpholino would be important to phenocopy the results obtained for fsta MO1. Other possibility 
would be the rescue the phenotype in the morphants by specifically re-expressing the targeted 
gene. In this respect, the use of a transgenic line with a construct of fsta under the control of a 
heat-shock promoter would help to clarify whether the observed effects were due to inactivation 
or activation of fsta gene.  
Moreover, since fsta is normally expressed early in development (Figure 4.4) therefore 
the knockdown of fsta should be performed just prior to HSC emergence. To confirm that 
observed phenotypes in HSC and venous specification were not secondary effects of an early 
phenotype that was not identified, it would be important to perform an experiment with a sense 
photo-morpholino, which can be inactivated at specific time points with UV light (365nm) 
exposure, thereby releasing the anti-sense morfolino; in this case just prior HSC emergence. 
Finally, previous studies showed that BMP signalling is important in multiple steps of HSC 
programming (McReynolds et al., 2007; Wilkinson et al., 2009). In zebrafish, BMP signalling has 
been shown to be required in the initiation and maintenance of HSC in the VDA (Wilkinson et 
al., 2009); BMP4, ligand of the BMP pathway, is necessary for runx1 expression in the DA 
(Wilkinson et al., 2009). BMP signalling has also been demonstrated to be important in venous 
programming in zebrafish (Wiley et al., 2011). It was shown that BMP signalling regulates 
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venous angiogenesis and that Bmp2b overexpression promotes ectopic sprouting in the PCV 
(Wiley et al., 2011). Wiley and colleagues demonstrated that BMP signalling mediates venous 
angiogenesis independently of a significant contribution of Vegf-A (Wiley et al., 2011). Besides, 
it is also known that Follistatin is a BMP antagonist, being often expressed in zebrafish in close 
proximity to expression regions of the BMP ligands, such as bmp2b and bmp4 (Bauer et al., 
1998). 
These findings strongly suggest that Follistatin acts via BMP in both HSC specification 
and vein angiogenesis processes. To address this hypothesis, it will be important to analyse the 
effects of morpholinos targeting the known zebrafish BMP ligands at the same time that fsta is 
knocked down. 
The observations here described indicate that fsta provides a way to down-regulate two 
different biological processes intimately related, stressing the complexity of fsta inputs in both 
HSC specification and vein angiogenesis processes.  
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The present study provides the first evidence for a role of fsta in both haematopoietic 
and venous programming in zebrafish. In fact, we were able to identify fsta as a novel signalling 
molecule important for HSC specification. We showed that knockdown of dll4 and runx1 leads 
to an increase of fsta expression levels. In addition, by using a morpholino to knockdown this 
gene, the functional characterisation of fsta was also performed, demonstrating that both 
embryonic haematopoietic development and vein sprouting were affected by loss of fsta.  
Importantly, the fact that fsta is expressed in the somites, and also plays a role in HSC 
specification, highlights the increasing evidence for an important regulatory role of the somites 
in HSC specification. Given the interesting phenotype observed in the fsta morphants, further 
functional analyses must be performed to understand the way by which this gene fits into the 
overall genetic regulatory network establishing and maintaining the HSCs. We speculate that 
both Dll4 and Runx1 are antagonizing Fsta. On the other hand, Fsta is antagonizing BMP which 
in turn is controlling runx1 expression and consequently HSCs emergence and/or specification. 
As future perspective, it will be interesting clarify whether fsta is an important regulator 
of primitive erythropoiesis, since this protein is expressed early during development and 
additionally because of known role of BMP in this process (Schmerer and Evans, 2003). 
Moreover, it will be important to identify the molecular mechanisms by which the endothelial and 
HSC programmes are modulated by fsta, as well as the specific co-modulators.  
Clearly, several important regulators of HSC programming are still unknown and remain 
to be determined. Follistatin gene is also present in humans and its functions are highly 
conserved between vertebrates. And so, the identification of the regulatory mechanism by which 
fsta modulates HSCs and venous programming would certainly, contribute to improve our 
understanding on the timed signals of haematopoiesis, and possibly for the design of efficient 
protocols for generation of HSCs in vitro, crucial for a more efficient use of stem cells based-
replacement therapy. 
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